Med Tech
Company reports

Books on medical technology

Business news

Plasticell wins £1.3m funding for cord blood stem cell manufacturing project
Innovate UK has awarded a grant of £1.3m to a research consortium led by Plasticell for a project to expand cord blood stem cell production using the company's technology. 10 Feb 2015

Consort Medical signs multi–year supply agreement for drug dose counter system
Hemel Hempstead-based Consort Medical plc has announced the conclusion of a new commercial supply agreement for its proprietary integrated dose counter (IDC) system. 5 Feb 2015

TxCell receives €1m payment for Ovasave clinical trial
T-cell immunotherapy developer TxCell SA has announced the receipt of the latest milestone payment of €1 million from the Ovasave agreement with Trizell Holding SA. 2 Feb 2015

Exco InTouch set for further growth and expansion following £3.2m investment
Exco InTouch has announced that it has earmarked capital from the £3.2 million raised from the company’s latest investment round to fund further growth and expansion into healthcare markets in 2015. Feb 2015

Gecko Biomedical receives €1.3m from Bpifrance to develop surgical adhesives
Paris-based Gecko Biomedical has announced it has received a €1.3 million loan from Bpifrance to advance development of its biodegradable surgical glues and patches for wound closure. 21 Jan 2015

FEops closes €1.3m investment to commercialise aortic valve preoperative planning system
Ghent-based FEops has secured €1.3 million series A financing round, led by Capricorn Venture Partners and PMV. 19 Jan 2015

DNA Electronics acquires nanoMR for $24m
London-based DNA Electronics Ltd, the inventors of semiconductor DNA sequencing technology, has completed the acquisition of nanoMR Inc. an Albuquerque-based developer of a system for rapid isolation of rare cells in the bloodstream. 19 Jan 2015

Karolinska University Hospital awards GE contract to build PET tracer production facility
Karolinska University Hospital and Stockholm County Council, Sweden have awarded GE Healthcare a contract to build a complete PET tracer production facility centre. 16 Jan 2015

Basildon and Thurrock Hospitals complete rollout of EMR system
Basildon and Thurrock University Hospitals NHS Foundation Trust has completed deployment of a trust-wide electronic medical records (EMR) system in a project costing £6.5 million. 16 Jan 2015

Birmingham and Solihull NHS Trust chooses Ascribe pharmacy system
Birmingham and Solihull Mental Health NHS Foundation Trust has chosen an e-pharmacy system from Ascribe after winning £500k from an NHS England fund to improve patient safety.  13 Jan 2015

Ascom wins service contract at South London & Maudsley NHS Trust
South London & Maudsley NHS Foundation Trust (SLaM) has awarded Ascom UK an eight-year contract to provide maintenance services for a staff alarm system. 13 Jan 2015

Nottingham City Council to invest in new biosciences incubator
Nottingham City Council is investing £6.5m from the local growth fund to build a bioscience incubator next to the existing highly successful BioCity complex. 6 Jan 2015

Bone therapeutics wins €1 million funding to develop bone cell matrix product
Belgian company Bone Therapeutics has received €1 million funding from the government of the Walloon Region to finance a new research project to investigate novel combined osteoblastic cell-matrix products for the treatment of large bone defects. 6 Jan 2015

Curie-Cancer and GamaMabs Pharma renew partnership to develop antibody for ovarian cancer
Curie-Cancer, the commercial arm of Institut Curie, and GamaMabs Pharma have announced the extension of their partnership to develop the 3C23K antibody for the treatment of gynaecological cancers. 19 Dec 2014

Selvita raises US$8.1m ahead of listing on Warsaw Stock Exchange
Polish drug discovery company Selvita has successfully completed its Initial Public Offering of 2,651,891 new shares amounting to PLN27.3m (US$8.1m), sold at the maximum announced price. 19 Dec 2014

Eli Lilly and Adocia collaborate to develop and commercialise rapid insulin technology
Eli Lilly and Adocia have announced a collaboration in which Lilly will be responsible for future development, manufacturing, and commercialization of Adocia's ultra-rapid insulin product, BioChaperone Lispro. 19 Dec 2014

HealthQuest Solutions awarded £1m to develop COPD management system
Southampton-based HealthQuest Solutions has been awarded a £960,000 contract by the Small Business Research Initiative (SBRI) to further develop its myCOPD Solution. 15 Dec 2014

Exco InTouch to address mHealth solutions in management of chronic conditions at 2014 mHealth Summit
Exco InTouch has announced it will speak in two mHealth solutions sessions focused on disease management and participate in a roundtable discussion on driving cross sector collaboration to improve patient care, reporting and outcomes. 5 Dec 2014

Medtronic gains European, US, Canadian clearance for takeover of Covidien
Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) have announced that the European Commission has conditionally cleared Medtronic’s proposed acquisition of Covidien. 28 Nov 2014

Covidien achieves CE Mark for Nellcor SpO2 patient monitoring system
Covidien has announced EU approval for its Nellcor Bedside SpO2 Patient Monitoring System, PM100N. The system currently is available in the European Economic Area (EEA), Australia and New Zealand.

Endomagnetics raises £2m for clinical trials and product development
Cambridge-based Endomagnetics has raised a further £2m to support its pivotal US clinical trial and the launch of a new cancer marker product in 2015. 26 Nov 2014

UK government invests £30m in emerging medtech companies and projects
Innovate UK and the UK Medical Research Council (MRC) announce awards totalling over £30m in companies and projects developing new medical treatments and technologies. 21 Nov 2014

Hospital sector investing in new equipment to drive efficiency gains
Hospitals in developed countries are becoming increasingly confident about their growth prospects for the year ahead despite rising costs and ongoing economic uncertainty, according to a survey by GE Capital. 18 Nov 2014

Karolinska Development secures life sciences funding from CP Group
Swedish life sciences investor,  Karolinska Development has secured investments and declaration of interest in further investments from CP Group subsidiaries Sino Biopharmaceutical Limited, Chia Tai Resources Limited, Chia Tai Medicines Holding Limited.

IBM and UK Science & Technology Facilities Council form Big Data Innovation Hub
IBM and the STFC Hartree Centre has created a Big Data innovation hub using IBM Big Data and Analytics technology to help organisations solve complex business problems. 12 Nov 2014

Hitachi and Danish hospital to study use of big data for improving hospital management
Bispebjerg and Frederiksberg University Hospital and Hitachi, Ltd.  have agreed to jointly develop solutions for increasing the efficiency of hospital management using IT at Hitachi's Denmark Big Data Research Laboratory, which opened on 5 Nov 2014. 12 Nov 2014

Help offered for medtech SMEs to enter multi-million-euro innovation competition
Product development contractor Pera Technology is searching for 10 small and medium sized medical technology firms who are seeking finance to develop new product and process ideas. 12 Nov 2014

Auspherix secures AU$1m funding to advance novel antibiotics pipeline
Sydney-based Auspherix Pty Ltd has secured a further AU$1 million in a series A financing from Australia’s Medical Research Commercialisation Fund (MRCF). 4 Nov 2014

Welch Allyn to add Gentag's NFC wireless technology to medical devices
Medical diagnostics device company Welch Allyn and Gentag, a pioneer in disposable wireless biosensors, have entered into an agreement to bring to market near field communications technology for medical devices and sensors 29 Oct 2014

Implandata announces closing of €3m funding round
Hannover-based Implandata Ophthalmic Products GmbH has announced the closing of a €3m Series B funding round that included Born2Grow Venture Partners as new investor. 28 Oct 2014

Boehringer Ingelheim implements IDBS laboratory E‑WorkBook suite
Pharma company Boehringerharma Ingelheim is rolling out the IDBS E-WorkBook Suite to manage lab information more efficiently and eliminate data silos. 28 Oct 2014

Exco InTouch first to comply with HIPAA, Safe Harbor and EU data protection rules
Exco InTouch has announced that it has become the first clinical research solutions provider to comply with the Safe Harbor, EU Data Protection and HIPAA (Health Insurance Portability and Accountability Act) regulations governing security and data privacy for patients. 15 Oct 2014

Auspherix and Domainex collaborate to combat drug-resistant bacteria
Cambridge-based Domainex Ltd and University of Technology Sydney spinout Auspherix Pty Ltd have announced a collaboration that will develop Auspherix’s novel anti-infective drug discovery programme towards the nomination of a clinical candidate. 15 Oct 2014

Karolinska Development appoints new CEO
Swedish medical technology company Karolinska Development has announced that Bruno Lucidi has been appointed as permanent CEO from today, in addition to existing positions in the company. 15 Oct 2014

CFI Medical awarded CE mark for Zero-Gravity radiation protection system
CFI Medical has received the CE mark for its Zero-Gravity Suspended Radiation Protection System Floor Unit for protecting clinicians when using X-rays in operating theatres. 14 Oct 2014

LoneStar receives CE mark for hydrogel implant for heart-failure treatment
California-based LoneStar Heart, Inc. has announced that it has received the CE Mark for its Algisyl-LVR hydrogel implant, the company’s lead product for the treatment of advanced heart failure. 14 Oct 2014

New Oncology and Gustave Roussy collaborate on genetic testing of tumours
Cologne-based cancer diagnostics developer New Oncology has announced that it has entered into a collaboration agreement with Gustave Roussy Cancer Campus, a research institute based in Paris. 14 Oct 2014

European Commission announces first SMEs to benefit from €3bn innovation fund 
The European Commission has published a list of the 155 Small and Medium-sized Enterprises (SMEs) that will be the first to benefit from its new 'SME Instrument' funding stream. 9 Oct 2014

Adaptimmune secures a further US$104m investment for product development
Oxford-based therapeutics company Adaptimmune Limited, has announced the completion of a US$104m series A financing round to advance its programmes for multiple cancer indications into the clinic. 9 Oct 2014

Paris Public Hospitals Group and Magnisense partner to develop tests for cardiovascular diseases
French hospital group AP-HP, (Assistance Publique-Hôpitaux de Paris), and diagnostics technology developer Magnisense have signed a partnership agreement to develop rapid portable diagnostic tests for cardiovascular diseases. 9 Oct 2014

Exco InTouch shortlisted for SCRIP Award
Exco InTouch has announced that its mDNA technology project team have been shortlisted for the “Best Technological Development in Clinical Trials” category for the 2014 SCRIP Awards. 3 Oct 2014

AstraZeneca and Cancer Research UK establish Cambridge lab to develop cancer drugs
MedImmune, the global biologics research and development arm of AstraZeneca and Cancer Research UK, with its commercial arm, Cancer Research Technology (CRT), are establishing a joint laboratory in Cambridge, UK to study novel biologic cancer treatments. 26 Sept 2014

Invest in Photonics chooses 20 European companies to pitch for €70m funding
Invest in Photonics 2014, a two-day international business partnering convention for photonics VC investment, has announced the selection of 20 emerging technology companies from around Europe to participate in a special funding session. 23 Sept 2014

Mayden awards contract to HealthMotive for NHS Spine integration software
Cloud solution developer Mayden has entered into a contract with healthcare systems developer  HealthMotive to incorporate HealthMotive’s Spin Messaging Handler (SMH) product into Mayden’s product offering. 23 Sept 2014

electroCore to present at European headache meeting on non-invasive vagus nerve stimulation therapy for cluster headache
The company will be presenting full data on their PREVA study, a randomized, multi-centre trial across several European countries at the EHMTIC meeting in Copenhaghen. 18 Sept 2014

Exco InTouch selected to present on mHealth innovation at HealthXL event in San Francisco
The company is presenting on its role as a key innovator in digital patient engagement and data capture solutions for clinical research at the HealthXL conference. 18 Sept 2014

Roche launches automated molecular diagnostic systems for blood and blood plasma screening
Roche has launched two integrated and fully automated molecular testing systems for blood and plasma donor screening, the cobas 6800 and 8800, based on Nobel-prize winning PCR technology. 2 Sept 2014

Exco InTouch achieves a first with mobile health apps for iOS, Android and Windows8
Exco InTouch has announced the availability of electronic clinical outcomes assessment (eCOA) apps on all three mobile operating platforms (iOS, Android and Windows8). 2 Sept 2014

Medtronic acquires Sapiens Steering Brain Stimulation for $200m
Medtronic has announced that it has acquired privately held Dutch company Sapiens Steering Brain Stimulation for approximately $200 million in an all-cash transaction. The deal strengthens Medtronic's capabilities in the modulation of brain function. 2 Sept 2014

Boston Scientific takes over Bayer's vascular disease business for 300m
Boston Scientific Corporation and Bayer Healthcare have announced the closure of the previously announced agreement for Boston Scientific to  purchase the Interventional business of Bayer Healthcare. 2 Sept 2014

Almac Group to invest £54m over five years in Northern Ireland
Enterprise, Trade and Investment Minister for Northern Ireland Arlene Foster has announced that the Almac Group is investing over £54 million and creating 348 high quality jobs over the next five years. 29 Aug 2014

Exco InTouch achieves ISO9001:2008 certification
The certification recognises that the company has developed and implemented a quality management system built around processes of the highest standards. 29 Aug 2014

Ablynx awarded €2.1m to develop nanobody treatment for eye disease
Ghent-based Ablynx has been awarded a €2.1 million grant by the Flemish Agency for Innovation by Science and Technology (IWT) to develop the use of nanobodies for a novel approach to the treatment of diseases of the eye. 29 Aug 2014

Edmond De Rothschild Investment Partners sells protein therapeutics investment to Johnson & Johnson company
Paris based Edmond De Rothschild Investment Partners (EdRIP) has announced that  one of its portfolio companies, Covagen A.G., has been acquired by Swiss company Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Company, which is one of the Johnson & Johnson Family of Companies. 26 Aug 2014

Roche and Garvan Institute of Medical Research partner to develop epigenomics technology
Roche and the Garvan Institute of Medical Research in Australia are collaborating to develop new technologies to accurately analyze regions of the epigenome using DNA sequencing. 19 Aug 2014

Oraya Therapeutics awarded grant to develop gold nanoparticle cancer therapy
Oraya Therapeutics, Inc. has been awarded a US$215,000 Small Business Technology Transfer Grant by NIH to investigate how Oraya Therapy can further enhance the treatment of wet age-related macular degeneration. 12 Aug 2014

Rapid Biosensor Systems appoints chair in move to IPO
Cambridge company Rapid Biosensor Systems Ltd has appointed John Reynolds OBE as Executive Chairman to take it to the next stage of growth. 12 Aug 2014

Wales gets world class life sciences business development centre
The Life Sciences Hub Wales was officially opened by Welsh Minister for Economy, Science and Transport, Edwina Hart on 17 July. The aim of the Hub, which is located in the Cardiff Bay area, is to create a vibrant life sciences ecosystem. 22 Jul 2014

Endomagnetics completes acquisition of the ACT Portfolio
The ACT portfolio provides Endomagnetics with a cancer therapeutics platform while maintaining synergies with its magnetic nanoparticle technology. 24 June 2014

Wiley acquires drug discovery software developer SimBioSys
Specialist information provider and publisher John Wiley has announced that it has acquired SimBioSys Inc., a provider of scientific software tools that facilitate the drug discovery process. 12 Jun 2014

Synthetic Biologics and Enterome Bioscience to study impact of beta-lactam antibiotics on intestinal bacteria
Antibiotics developer Synthetic Biologics and gut microbiome specialist Enterome Bioscience SA will collaborate in genomic research on the effects of beta-lactam antibiotics on the gastrointestinal microflora of human patients. 11 Jun 2014

Clearbridge BioMedics launches device that isolates circulating tumour cells from blood
Clearbridge BioMedics has launched a new cancer diagnostic device, the ClearCell FX System, which is able to isolate and capture circulating tumour cells (CTCs) from a blood sample. 5 Jun 2014

Adaptimmune announces partnership with GSK for cell-based cancer therapies
Adaptimmune Limited has announced  a multi-million dollar strategic collaboration and licensing agreement with GlaxoSmithKline (GSK) for the development and commercialisation of its lead clinical cancer programme. 5 Jun 2014

Almac validates novel gene biomarker test for ovarian cancer patients
The company has announced the validated results of the ALM AADx assay, a gene expression test that identifies a subgroup ovarian cancer patients that have a good prognosis following chemotherapy. 5 Jun 2014

Pharma industry encouraged to adopt mobile solutions for clinical trials efficiency
Exco InTouch, a provider of patient engagement and data capture solutions for clinical research and healthcare providers, is championing the industry to adopt mobile electronic patient reported outcome. 5 Jun 2014

LayerWise wins GE’s global competition for 3D printing of metal parts
GE has chosen LayerWise as the winner of its worldwide open innovation challenge, the 3D Printing Production Quest, to produce complex medical imaging device parts with high precision. 4 Jun 2014

Provence Technologies acquires Synprosis
Marseille-based chemistry research company Provence Technologies Group has acquired Synprosis, a specialist in the chemical synthesis of peptides and proteins for therapeutic use. 4 Jun 2014

QuantuMDx closes $8.42m funding for prototyping handheld DNA diagnostics device
The Newcastle-based diagnostics developer has announced it has closed an $8.42m funding round syndicated with philanthropist private investors and the University of Newcastle upon Tyne. 4 Jun 2014

GE and Tesla Engineering to produce ultra high strength MRI scanners
GE Healthcare and Tesla Engineering Ltd. have announced that they will collaborate to produce ultra high field 7.0 tesla whole-body MRI scanners for scientific and medical research. 28 May 2014

Sure Chill Company awarded $1.4 million to develop portable vaccine cooling box
The company has been awarded $1.4 million by the Bill & Melinda Gates Foundation to develop an innovative long-life vaccine cooler for use in remote undeveloped places. 21 May 2014

Jellagen wins £550,000 investment to produce medical grade collagen
Jellagen Pty Ltd has announced a £550,000 equity investment led by Finance Wales with co-investment by six members of xénos, the Wales Business Angel Network and SWAIN. 21 May 2014

Calcivis receives £1.3m investment for tooth decay assessment system
Oral health company Calcivis has received a UK Biomedical Catalyst award co-funding a £0.5m development programme and raised a further £0.8m in equity funding from existing investors. 2 May 2014

Enterome raises further €10 million funding for genotyping technology
Enterome Bioscience SA has raised €10m in the first tranche of a Series B fund raising to develop disease management solutions based on the gut microbiome. 2 May 2014

Cambridge University Hospitals invests £120m in medical and education centre
Cambridge University Hospitals NHS Foundation Trust (CUHT) and John Laing have invested £120 million in The Forum, a mixed-use medical and education facility on the Cambridge Biomedical Campus.

Codasip secures $2.8m investment for ASIP technology
Application-specific processor developer Codasip, has announced that it has closed its first round of public funding from Czech venture capital firm Credo Ventures. 25 Apr 2014

Quantum Imaging secures £1.6m funding to develop portable magnetometry device
The company has secured a £1.6m investment by IP Group and the University of Leeds to enable the development of a portable medical imaging device based on its magnetometry technology. 9 April 2014

TI Pharma joins consortium in €7.8m project tackling neglected parasitic diseases
An international group of academic institutions and companies is joining forces to develop novel drugs against parasites in an EU-funded project led by VU University Amsterdam. 4 April 2014

GE Healthcare to acquire operating room management system provider CHCA
GE Healthcare has announced that it will acquire CHCA Computer Systems Inc., a Canadian operating room (OR) management and analytics solutions provider. 4 April 2014

Exco InTouch to unveil partner network at Partnerships in Clinical Trials Congress
Exco InTouch, a provider of patient engagement and data capture solutions, will unveil the Exco Valued Partner Network at the Congress in Las Vegas this week (30 March - 2 April 2014). 28 Mar 2014

Amputees in Action simulates extreme casualty situations for medical training
Amputees in Action, the UK’s largest provider of amputee actors and special effects artists, is extending its medical training expertise to cover extreme working environments. 20 Mar 2014

Endomagnetics wins business award for breast cancer treatment product
Cambridge-based Endomagnetics has been given the award for Best New Product or Business Model in this year’s Business Weekly awards for companies in the East of England. 20 Mar 2014

Health science network for North West England launched
The North West Coast Academic Health Science Network (NWC AHSN), one of 15 such networks in England, has officially launched with an event to connect healthcare, academia and industry in the region. 20 Mar 2014

Vodafone and AstraZeneca in partnership to provide mobile health services for cardiovascular patients
Vodafone and AstraZeneca have announced a global partnership to use Vodafone's mobile technology and systems to help cardiovascular patients and their healthcare professionals manage their care. 13 Mar 2014

Welsh graphene company to raise £10m on UK AIM to fund large scale production
South Wales graphene company Haydale has announced plans to raise up to £10 million ($16.6 million) via an IPO on the UK's Alternative Investment Market to fund development of its cold plasma based mass-production system. 18 Mar 2014

Incanthera acquires second cancer drug pipeline with takeover of Onco-NX
The deal will see the companies combine their expertise in targeted anti-cancer drugs, to develop a ground-breaking, therapeutics pipeline. 13 Mar 2014

Boston Scientific's REBEL coronary stent system receives CE mark
The REBEL Platinum Chromium Coronary Stent System is the company's latest generation bare metal stent for the treatment of coronary artery disease (CAD). 13 Mar 2014

Roche HIV-1 dual genetic test given EU approval
Roche has announced that its dual-target HIV-1 qualitative test, v2.0 has received the CE Mark certifications, allowing it to be sold for clinical use in the EU. 24 Feb 2014

Exco InTouch appoints new VP of operations
Exco InTouch has announced the appointment of Laurence Burke as Vice President of Operations. 20 Feb 2014

Cardio3 BioSciences receives €4.0m investment for commercialisation of C-Cathez
Cardiac technology company Cardio3 BioSciences SA has received €4.0 million of funding from the Walloon Region of Belgium to commercialise its C-Cathez intra myocardial injection catheter in the US. 6 Feb 2014

Bone Therapeutics awarded €3.8 million research grant
Bone Therapeutics has been awarded a share of a Marie Curie grant totalling €3.8 million to develop bio-mimetic and bio-active materials. 6 Feb 2014

Synthelis raises €610,000 to develop manufacturing services for membrane proteins
Synthelis, a company specializing in the production and characterization of therapeutic targets and antigens, has secured initial backing of €610,000 from a group of French investors. 6 Feb 2014

Siemens Healthcare Diagnostics partners with Pfizer to develop diagnostic tests
Siemens Healthcare Diagnostics and Pfizer are partnering to develop in vitro diagnostic tests for therapeutic products across Pfizer’s pipeline. 4 Feb 2014

Tech sector in UK shows strongest growth for a decade
The UK tech sector increased its growth during the fourth quarter of 2013, with strong inflows of new work driving the steepest expansion of business activity for almost a decade, according to KPMG/Markit. 31 Jan 2014

Philips launches new Healthcare Informatics Solutions and Services Business Group
The new group offers hospitals and health systems customised clinical programs, advanced data analytics and interoperable, cloud-based platforms for implementing new models of care. 28 Jan 2014

Exco InTouch completes HIPAA security audit
Exco InTouch has announced that it has successfully completed an independent audit to assess compliance utilizing the National Institute of Standards and Technology guidelines for HIPAA security. 27 Jan 2014

QuantuMDx launches crowdfunding campaign to help eliminate malaria with handheld lab
DNA diagnostics company QuantuMDx will launch an Indiegogo crowdfunding campaign to support malaria eradication worldwide by further developing and trialling their handheld laboratory which can identify malaria DNA in 15-minutes. 9 Jan 2014

3D orthotics printer wins £860k investment
Burnley based FDM Solutions has secured a £860,000 investment from the North West Fund for Venture Capital and Lancashire’s Rosebud Fund to produce made-to-measure insoles for the NHS using its 3D printing system. 9 Jan 2013

CEO of QuantuMDx awarded OBE in New Year's Honours list
QuantuMDx Group’s CEO and Co-Founder Elaine Warburton has been awarded an OBE in the New Year’s Honours list 2014 for her services to health innovation over the last 25 years. 3 Jan 2013

Bioaxial secures €1.9m funding to develop fluorescence microscopy instruments
Paris-based Bioaxial has completed  equity investment by three new large investors. This capital will back the commercial launch of Bioaxial’s first product, an optical microscopy module. 5 Dec 2013

Trinity Biotech exhibits cardiac diagnostics point-of-care system at MEDICA
Trinity Biotech is displaying its new 15-minute-analysis Meritas Troponin I (TnI) point-of-care test in Dusseldorf this week. 20 Nov 2013

Aerotel showcases smallest hand-held ECG monitors at MEDICA
Aerotel Medical Systems is presenting two new models of what it claims are the world’s smallest and most accurate hand-held ECG monitors at Medica 2013. 20 Nov 2013

ARC launches non-touch medical thermometers at MEDICA
Belfast company ARC is launching four new highly accurate non-touch thermometers at MEDICA this week. 20 Nov 2013

Capillary Film Technology launches microfluidic device manufacturing technology at MEDICA
Biotechnology developer Capillary Film Technology Ltd (CFT) has announced the launch of a new fluoropolymer Micro Capillary Film (MCF) technology. 20 Nov 2013

Immunocore achieves research milestone in GlaxoSmithKline collaboration
Oxford-based Immunocore has announced the achievement of the first cancer drug development milestone in its research and licensing agreement with GSK, triggering a first payment. 7 Nov 2013

East Midlands pharma sector regenerating following AstraZeneca research lab closure
The pharmaceutical industry in the UK's East Midlands is seeing growth in new businesses following AstraZeneca’s closure of its Charnwood research labs, according to industry association Medilink East Midlands. 31 Oct 2013

JDRF commits $5m to carry diabetes therapies through "valley of death"
Diabetes charity JDRF and technology development company PureTech, have launched T1D Innovations, an organisation focussed on accelerating the development of innovative diabetes therapies. 16 Oct 2013

Clinlogix acquires ikfe CRO
Clinical research organization Clinlogix has expanded operations in Europe with the acquisition of Mainz-based ikfe CRO GmbH. 16 Oct 2013

immatics seals €34m financing for development of renal cancer vaccine
Tuebingen-based immatics biotechnologies has closed a €34 million Series D financing round to fund development of its lead multi-peptide cancer vaccine, IMA901. 16 Oct 2013

Eye movement test to check for psychiatric disorders wins award
An eye movement test to assist diagnosis of major adult psychiatric disorders has won the Converge Challenge, a national contest recognising Scotland’s entrepreneurial innovations. 11 Oct 2013

Cambridge Innovation Capital raises £50m to invest in local hi-tech companies
CIC has announced that it has raised an initial £50m from long-term institutional and strategic investors to support companies based in the 'Cambridge Cluster' of science and business parks. 10 Oct 2013

Touch Bionics executive receives Scottish engineering honour
The Chief Technical Officer of prosthetics developer Touch Bionics has been inducted into the Scottish Engineering Hall of Fame. Hugh Gill takes his place alongside Scottish engineering pioneers such as James Watt and Thomas Telford. 10 Oct 2013

QuantuMDx wins NE innovation award for handheld DNA sequencer
Newcastle-based diagnostics company QuantuMDx has been awarded the Insider's 'Made in the North East' Life Sciences trophy in recognition of its ground-breaking handheld DNA sequencer. 10 Oct 2013

Novartis Ultibro Breezhaler approved by EC and Japan for treating COPD
Novartis has gained EC and Japanese approval for its Ultibro Breezhaler to treat various symptoms in adult patients with COPD. 26 Sept 2013

European Parliament could cripple medical innovation in Europe
The European Parliament’s Committee for Environment, Public Health and Food Safety (ENVI) has voted in favour of draft legislation that trade body Eucomed says could cripple the medical technology sector in Europe and delay patients' access to innovative products. 25 Sept 2013

EMIS takes over Ascribe for £57.5m
EMIS Group plc, the UK's leading software provider for GP practices, has bought pharmacy systems supplier Ascribe from private equity group ECI. 13 Sept 2013

PV Nano Cell's copper inks for printed electronics attract $3.5m investment
Israeli company PV Nano Cell Ltd, which develops materials for inkjet printing of conductive patterns in solar cells and printed electronics, has completed a funding round of about $3.5 million. 4 Sept 2013

ObsEva announces €26m series A funding from venture capital firms
Swiss company ObsEva has announced the closing of a CHF32m Series-A financing round led by Sofinnova Partners, and co-led by Sofinnova Ventures and Novo A/S. 30 Aug 2013

ValiRx wins €1.6m grant to develop genetics-based cancer treatment
ValiRx plc and consortium member Pharmatest Services have been awarded a €1.6 million Eurostars grant to progress the pre-clinical studies of its novel product VAL101. 29 Aug 2013

World’s pharmaceutical development and manufacturing base moving to India
The India Brand Equity Foundation (IBEF) predicts that the Indian pharmaceutical market will progress from the major generics producer to a world centre for development and production of patented products. 20 Aug 2013

Medilink East Midlands wins £2.1m funding from ERDF for advisory service
Medilink East Midlands will be able to continue its iNet business advisory service for a further two years with an additional £2.1 million from the European Regional Development Fund (ERDF). 31 July 2013

UK government announces £93m support for medtech sector
The UK government has announced awards from the Biomedical Catalyst fund for research projects, a new National Biologics Manufacturing Centre and joint investment in medtech companies by the Technology Strategy Board and the Department for Health. 31 July 2013

Sensimed AG completes €20m financing round
Swiss company Sensimed AG has announced the completion of its Series C financing round for a total of CHF25m (€20m) for its glaucoma monitoring system. 23 July 2013

EC invests €77m into I4MS initiative to boost 200 hi-tech SMEs
The European Commission is launching a new €77 million fund from its 7th R&D Framework Programme (FP7) to  help high-tech SMEs exploit the potential of ICTs to boost their businesses. 17 June 2013

Strathclyde-based chemical manufacturing research centre receives £34.2m boost
The EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation (CMAC) in Strathclyde has received an £11.4 million cash injection from the Higher Education Funding Council for England (HEFCE), supported with £22.8 million industry and charity contributions. 6 June 2013

TSB announces funding for 3D printing projects
Research and development projects using 3D printing techniques have received a funding boost from the UK Technology Strategy Board and three research councils. 6 June 2013

HistoIndex chooses London BioScience Innovation Centre as European base
Singapore-based medical imaging company HistoIndex has become the 50th life science company in the London BioScience Innovation Centre (LBIC). 6 June 2013

Alliance Boots to set up health and wellness business incubator in Nottingham
Alliance Boots is partnering with BioCity to establish a new business incubator focused on health and wellness called MediCity in the Beeston area of Nottingham. 30 May 2013

Cerus Endovascular secures £600,000 for device to treat brain aneurysms
Cerus Endovascular Ltd has secured investment from The North West Fund for Biomedical to further develop its implantable medical device for treating intracranial aneurysms. 21 May 2013

GE Healthcare to supply Kent & Medway Medical Imaging Consortium with collaborative radiology system
East Kent Hospitals University NHS Foundation Trust has awarded GE Healthcare a seven-year managed service contract to supply imaging services to the four hospital trusts of the Kent & Medway Medical Imaging Consortium. 21 May 2013

Aesica partners with the University of Nottingham to develop novel amide chemical synthesis techniques
Aesica has announced a partnership  to develop alternative methods of amide bond synthesis for pharmaceutical manufacturing. 21 May 2013

BioCity to develop BioHub at AstraZeneca's Alderley Park site
BioCity Nottingham Ltd, the UK’s leading provider of life sciences business incubation services, has been appointed by AstraZeneca to establish a new centre for bioscience companies at Alderley Park in Cheshire. 21 May 2013

Hugo Technology sees year-on-year growth
Despite continuing uncertainty within the UK economy, medical technology repair and maintenance firm, Hugo Technology, has continued to grow during 2012.

Recipharm manufacturing site in France approved by Japanese drug agency
Recipharm’s solid dose facility located in Fontaine, France, has been approved for supply of manufactured products to the Japan’s pharmaceuticals market. 19 Apr 2013

AstraZeneca outlines major restructuring of R&D and strategy to return to growth
AstraZeneca has announced plans for to establish a new global R&D centre and corporate headquarters in Cambridge in the UK by 2016. The move is part of the company’s proposals to create strategic global R&D centres in the UK, US and Sweden to improve pipeline productivity and to establish it as a global leader in biopharmaceutical innovation. 4 Apr 2013

InteRNA Technologies secures additional equity financing for melanoma treatment
Utrecht-based InteRNA Technologies B.V. has closed an equity financing round, with new investors including the ‘Innovation & Investment Fund Gelderland’, managed by PPM Oost and several business angels. 4 Apr 2013

Anglia Ruskin to start construction of Medical Business Innovation Centre
Construction of the first building of the new Anglia Ruskin University medtech campus will start at the beginning of April. The £6 million Medical Business Innovation Centre (MedBIC) will be built on the Chelmsford campus. 25 Mar 2013

Edgbaston Medical Quarter forms world class stronghold for medical technology development
The EMQ, a cluster of medical organisations and medical technology companies, was officially launched at the Medilink UK Life Sciences Summit in Birmingham this week. 20 March 2013

Novo Nordisk’s insulin delivery device approved in China
Novo Nordisk’s latest device for insulin delivery, NovoPen 5, has been approved by the Tianjin Food and Drug Administration for launch in China. 20 Mar 2013

Plessey Semiconductors expands  distribution network in Asia
Plessey and Supreme Components Inc (SCI) have signed a distribution agreement for the Singapore, Thailand, Malaysia and Vietnam markets. 20 Mar 2013

Diagnostic Healthcare secures £1m investment to expand services
The company will use the investment to expand its diagnostic services, increase community services in more locations across and expand its portfolio of medical equipment. 20 Mar 2013

MTB Europe launches new Marcomms Service for medical technology vendors
In response to a huge rise in requests and having established a clear market need, MTB Europe has launched a range of marketing and communications services for vendors and suppliers in the medical technology sector. 11 Mar 2013

Anglia Ruskin MedTech Campus offers gateway to the NHS market
The MedTech Campus is launching its Business Network Services at the Healthcare Innovation Expo on 13 March, to give companies the opportunity to access NHS clinicians, academics, industry and customers. 8 Mar 2013

AstraZeneca and Exco InTouch to develop chronic disease management software
AstraZeneca and patient management systems developer Exco InTouch have announced a programme to develop interactive mobile phone and internet-based health tools for tracking and managing chronic conditions. 28 Feb 2013

Medtech and life sciences sector in East Midlands standing up to the recession
Medilink East Midlands says that the sector has overcome the business support difficulties posed by significant changes in government policy over the last three years. 19 Feb 2013

Oxford Nanopore announces further collaborations for nanopore sensing technology
The company has completed agreements with the University of Illinois, Brown University, Stanford University, Boston University, University of Cambridge and the University of Southampton. 13 Feb 2013

Curie-Cancer and GenoSplice Technology in genomics informatics partnership
Curie-Cancer, part of Institut Curie, and GenoSplice Technology have formed a partnership to combine their expertise in genomics to develop new cancer treatments. 13 Feb 2013

Big pharma companies facing US$100bn shortfall in growth due to flat sales
The largest pharmaceutical companies are facing a widening growth gap that will increase pressure to drive growth through mergers and acquisitions (M&A) to bridge the gap. 7 Feb 2013

NHS leasing wider range of medical equipment, according to SFS research
Leasing in the NHS is growing in popularity and extending to a wider range of equipment, according to a new analysis by Siemens Financial Services (SFS) of leasing activity in 2012. 4 Feb 2012

Bone Therapeutics raises €7.7m to fund bone cell therapy pipeline
The company has successfully closed a Series D funding round, raising €7.7m from current investors and the Walloon Region of Belgium. 30 Jan 2013

Philips and University of Malaya to establish centre for sleep disorders
South East Asia’s first excellence centre for sleep disorders will be established at the University of Malaya Specialist Centre (UMSC) in collaboration with Philips Malaysia. 23 Jan 2013

Rosetta Capital buys SEK220 million share in Karolinska Development holdings
Karolinska Development AB has announced that a syndicate led by the life science investor Rosetta Capital will acquire a minority share in Karolinska Development’s holdings in 13 of its 25 portfolio companies for SEK 220 million. 21 Dec 2012

NanoKTN urges UK SMEs to take advantage of £10m R&D funding call
UKTI is calling for innovative proposals from SMEs that focus on projects that advance the development of a recent technological discovery or breakthrough in the context of significant and identifiable technological risk. 4 Dec 2012

Endomagnetics selected as high-potential company by Future 50 Project
Endomagnetics is developing nanomagnetic technology as an alternative to the radioisotopes currently used for tracking the spread of cancer. 30 Nov 2012

North West Fund for Biomedical invests £400,000 in local medtech companies
This is the third tranche of funding for both companies, which received initial Pathfinder investments in 2011 and further development funds earlier this year. 23 Nov 2012

UK Business Secretary announces a few more peanuts invested in tech sector
The Technology Strategy Board will invest up to a further £6 million in new Launchpad competitions to accelerate the development of existing clusters of innovative high growth SMEs around the UK. 21 Nov 2012

QuantuMDx acquires identity testing services company Northgene
The acquisition will provide funds to further develop NorthGene’s laboratory and staffing infrastructure, secure various laboratory accreditations and to expand the Company’s test portfolio and DNA analysis services. 14 Nov 2012

Hand-held device can diagnose flu virus strains in minutes
Newcastle-based OJ-Bio has secured funds to further develop a device for the rapid, simple and low cost diagnosis of flu and other viruses. 13 Nov 2012

phenox receives CE Mark approval for brain embolisation device
The phenox p64 flow modulation device is an intraluminal flow diverter intended to treat complex intracranial aneurysms and dissections. 6 November 2012

Zilico secures further £750K funding for cervical cancer test
Zilico Ltd has secured £750K investment from The North West Fund for BioMedical. This follows £1m investment announced in June 2012. 6 Nov 2012

UK government to invest £7m to promote additive manufacturing
Grants for collaborative R&D projects in additive manufacturing, also known as 3D printing, will be awarded through an open competition. 26 Oct 2012

Record year heralds expansion for Raleigh Coatings
Staffordshire-based Raleigh Coatings is looking to create skilled jobs at a new production facility following a record year for sales and turnover. 26 Oct 2012

Manchester United appoints Toshiba as official supplier of medical systems
Toshiba Medical Systems will provide state-of-the-art medical equipment to a new medical centre at the club’s training ground. 26 Oct 2012

More collaboration between business and universities needed to boost UK economy
UCB has called on the UK Government to ensure that measures to strengthen partnerships between universities, business and the NHS actually deliver results. 24 Oct 2012

Flaws in EU regulation of medical devices, says BMJ
A joint undercover investigation by the BMJ and the Daily Telegraph has exposed flaws in the EU system used to grant market access for devices such as replacement hips, cardiac defibrillators, and breast implants. 24 Oct 2012

European medtech associations form new alliance to drive industry forward
Eucomed and EDMA, the European Diagnostic Manufacturers Association, have formally launched a new alliance called MedTech Europe. 10 October 2012

Select Bio Laboratories moves into BioCity Scotland
Lanarkshire-based biosciences incubator, BioCity Scotland, has signed a deal with the Select Pharma Group to move its contract testing laboratory services onto the site this month. 9 Oct 2012

Boston Scientific to acquire Rhythmia Medical
Rhythmia Medical, Inc. is a developer of mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter. 9 Oct 2012

ABHI launches website to promote UK medtech exporters at trade fairs
ABHI International has launched ABHI UK Pavilion to promote UK medical technology manufacturers and help SMEs gain access to foreign markets. 26 Sept 2012.

St Jude mini neurostimulator to treat chronic migraine gains EU approval
The Eon and Genesis systems deliver peripheral nerve stimulation (PNS) of the occipital nerves to manage the pain and disability associated with intractable chronic migraine. 21 Sept 2012

ASEAN Medical Device Directive to give US$400m boost to market
A new co-operation agreement between 10 South East Asia countries to standardize medical device registration will allow suppliers to take advantage of more than $400M of new emerging business in four key areas. 21 Sept 2012

Boston Scientific expands cardiology portfolio with acquisition of BridgePoint Medical
BridgePoint Medical is a privately held company that has developed a catheter-based system to treat coronary chronic total occlusions (CTOs). 20 Sept 2012

Case study: Finesse Medical streamlines processes with business management solution. 17 Sept 2012

Sygnature Discovery strengthens management team
Nottingham-based Sygnature Discovery Limited appointed Colin Sambrook Smith to the newly-created role of Head of Computational Chemistry and Informatics. 4 Sept 2012

British Business Embassy summit on assistive technology heads to birthplace of Paralympics
A unique business summit hosted today by UKTI presents the UK’s excellence in assistive medical technologies to international business leaders. The group will spend part of the day in Stoke Mandeville Hospital, the birthplace of the Paralympics. 3 Sept 2012

German medical technology sector increases revenues to €21.4bn
BVMed, the German medical technology association, has reported that the total revenue of medical technology companies in Germany increased by 6.9% to €21.4bn in 2011, with exports increasing over 10%. 31 Aug 2012

BioCity Scotland appoints new board member
BioCity Scotland, the centre for life science businesses in Newhouse, Lanarkshire has announced the appointment of Dr Allison Jeynes-Ellis as a new Board member.

Technology Strategy Board outlines £250m investment in UK business growth
The Technology Strategy Board has outlined how up to £250m will be invested in 60 competitions for funds designed to stimulate business growth. 23 July 2012

DNA Electronics to present at UKTI’s Healthcare and Life Sciences Summit
The Summit is hosted by UK Trade & Investment (UKTI) as part of the business events around the London Olympic games. 25 July 2012

Cellular Systems awarded TSB/ DEFRA research grants
Nottingham BioCity-based Cellular Systems has been awarded grants for a poultry disease detection system and egg shell waste product development. 18 July 2012

Calixar and Synthelis partner to provide membrane protein services
Two French companies specialising in membrane proteins, Calixar and Synthelis, have entered into an alliance for the production and isolation of all types of target membrane proteins. 17 July 2012

EyeBrain researchers move into Brain and Spine Institute
The aim is to foster scientific exchange with ICM researchers and speed up the development of clinical research tools for neurological diseases. 16 July 2012

Places in US trade mission offered to medtech SMEs
Twenty companies will be chosen to travel to Boston, Massachusetts to take part in the Future Health Mission 2012 at the end of September. 3 July 2012

Johnson & Johnson completes $20bn takeover of Synthes
Synthes has been integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson. 19 June 2012

TLT appoints Dr Art Tucker as Clinical Director  
Dr Tucker is a Principal Clinical Scientist and Vascular Researcher at St Bartholomew’s Hospital, London; Honorary Reader at The William Harvey Research Institute, Queen Mary University of London. 18 June 2012

Calixar secures €875K funding round to develop membrane protein services
The funds will enable Lyons-based Calixar to develop its international operations for membrane protein services and move its research programs forward. 18 June 2012

UK government funds 16 R&D projects for hi-tech manufacturing
The UK Technology Strategy Board and the Engineering and Physical Sciences Research Council are to provide £6.5 million grant funding to support the development of new technologies in manufacturing. 15 June 2012

Boston Scientific completes acquisition of Cameron Health
The acquisition of San Clemente-based Cameron Health, Inc adds the company's subcutaneous implantable cardioverter defibrillator, the S-ICD System, to Boston Scientific's portfolio. 11 June 2012

TSB awards £1m funding to develop small molecule drug platform
Three companies, Isogenica, Biolauncher, and Cresset Group, have been awarded £1m funding from the UK Technology Strategy Board to develop a highly-scalable approach to small molecule drug discovery. 7 June 2012

Abbott awarded CE mark for PLEX-ID rapid microbial identification system and clinical tests
PLEX-ID, which is based on molecular diagnostic technologies, addresses a significant unmet need for rapid detection and identification of a broad range of microbes that cause infections in patients. 28 May 2012

Idaho Technology receives FDA 510(k) clearance for rapid respiratory pathogen detection system
Idaho Technology, Inc. has announced US FDA 510(k) clearance of five additional pathogens for its FilmArray RP system and the launch in European markets. 28 May 2012

UK medtech sector boosted by launch of Anglia Ruskin MedTech Campus
The Anglia Ruskin MedTech Campus will provide one of the world’s largest health innovation spaces, with the aim of establishing the UK as a global force in the sector. 22 May 2012

Sygnature Discovery and Pneumolabs partner in drug development services
The companies have entered into a strategic alliance to provide a fully-integrated drug discovery service to accelerate clients’ drug discovery programmes into development. 17 May 2012

Conference on funding innovation in biotech and medtech
This event, on 13 June 2012, will help identify the best routes to accessing funding programmes that match project needs. 14 May 2012

Manchester university spin-out turns into world leading quantum dot producer
Quantum dot producer Nanoco has grown from a university spin-out to one of the UK’s most significant nanotechnology companies. 8 May 2012

Click on the arrows above to see more products

Seminar in Birmingham on market for devices for diabetics
Commercial opportunities to develop new devices for diabetics will be showcased in the first of a series of events by medtech industry specialist Medilink. 6 May 2012

German medtech sector driving innovation and exports
Nearly 50% of German medical technology companies are expecting increased profits this year and the healthcare sector has higher revenues than the automotive sector, at €278bn. 30 Apr 2012

DiaGenic and GE Healthcare to develop blood-based test for early Alzheimer's
The blood-based test will use DiaGenic’s peripheral gene expression profiling in patients with mild cognitive impairment, a disorder associated with risk for Alzheimer’s Disease. 30 Apr 2012

Memorial Sloan-Kettering Cancer Center and IBM collaborate to develop oncology decision support with IBM Watson
The tool, built upon IBM Watson, will provide medical professionals with improved access to current and comprehensive cancer data and practices. 30 Apr 2012

Celtic Therapeutics invests $50M in developing antibody drug conjugates
A new company will be based in Switzerland to develop, ADCs (developed in London!) which are fast becoming the most exciting new class of oncology drugs as they combine the specificity of antibodies with the cytotoxic power of novel “warhead” chemistries. 30 Apr 2012.

Elekta wins Queens Award for export performance
Stockholm-headquartered Elekta, has received the Queen's Award for Enterprise 2012 in the International Trade category for the performance of its Crawley, UK plant. 25 Apr 2012

Immunodiagnostic Systems Holdings receives Queens Award for Enterprise
More than 90% of IDS’ products are exported internationally and the Company has continually grown its export revenues and profits over the last six years. 25 April 2012

Isansys Lifecare achieves CE Mark for LifeTouch Patient Surveillance System
The LifeTouch is a cloud-ready medical device, and the first to be certified as a Class IIa medical device under the European Medical Device Directive (MDD). 18 Apr 2012

Westhouse Medical Services acquires glaucoma treatment from Sunridge International
Westhouse Medical Services Plc. has entered into a US$2m cash and bond deal to acquire the patents, manufacturing rights, distribution agreements and intellectual property for Pneumatic Trabeculoplasty. 18 Apr 2012

UK government to open £180m funding to support biotech and medtech companies
The Biomedical Catalyst fund for innovative SMEs and academia to develop solutions to healthcare challenges will open for applications at the end of April. 14 Apr 2012

New guide to procurement in the NHS
The complex routes to NHS procurement are mapped out in a new publication, The NHS Procurement Guide, published quarterly by Medilink UK. 3 Apr 2012

BioCity Scotland offers £10,000 Dragon's Den prize for entrepreneur boot campers
The Boot Camp is a three-day intensive business development programme designed to prepare scientists to be their own boss. 3 Apr 2012

Promethera Biosciences raises €23.6m series-B financing
Among the new investors are the venture arms of pharmaceutical industry leaders Boehringer Ingelheim and Shire, Japanese investment fund Mitsui Global Investment, US company ATMI and Belgian venture capital fund Sambrinvest. 28 Mar 2012

Enterome raises €5m series A funding
This funding follows a previous seed round that raised €1.5 million from Seventure Partners (Natixis) and INRA Transfert. It will allow further development of biomarkers for abnormal flora of the human intestine. 28 Mar 2012

Eucomed launches European medtech conference vetting system
The independent Compliance Panel of Eucomed has launched the system to review third-party educational conferences for compliance with ethical practices. 28 Mar 2012

Stevenage BioScience Catalyst and Kurma Life Sciences Partners collaborate to boost investment in UK bioscience
The parties will work together and independently on sourcing investments based on innovative science, from both academia and the pharmaceutical industry. 26 Mar 2012

Domain Therapeutics wins €933,000 grant for schizophrenia drug project
Domain Therapeutics has announced that the ATHOS project has been selected for French government funding. 22 Mar 2012

Michelson Diagnostics secures £600k investment for further growth
Michelson Diagnostics has announced a further investment of £607k by shareholders Octopus Investments, Catapult Venture Managers and London Business Angels. 22 Mar 2012

Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery

Siemens announces successful completion of bid for RuggedCom Inc.

Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment

Boston Scientific to Acquire Cameron Health, Inc.

Mobius Life Sciences Fund invests in XenoGesis Limited
XenoGesis Limited is a contract research organisation (CRO) set up by ex-AstraZeneca researchers. The financing is part of a £135,000 investment round. 12 Mar 2012

BioCity Nottingham appoints life sciences industry leader Dr John Brown to board
Dr Brown's arrival closely follows the launch of BioCity Scotland, and marks another step-change in the growth ambitions of the company.

NanoKTN announces success of Plessey EPIC sensor resulting from TSB funding
Through support offered by the NanoKTN and JEMI UK, Plessey Semiconductors has been able to promote its product to potential end-users, vital in the early stages of the product’s marketing. 12 Mar 2012

Helios BioSciences becomes 27th company to move into Biocitech technology park
Biocitech, the Paris life sciences technology park, has announced the arrival of Helios BioSciences, a provider of bioinformatics services in support of the drug discovery process. 9 Mar 2012

Boston Scientific to acquire Cameron Health for initial US$300m
California-based Cameron Healthhas developed a subcutaneous implantable cardioverter defibrillator — the S-ICD System. 8 Mar 2012

BioCity Scotland signs up first business partner
BioCity Scotland, the newly-opened life sciences cluster in Newhouse, Lanarkshire, has signed a three-year agreement with leading patent attorneys HGF making them the first corporate partner to join the BioCity team. 29 Feb 2012

Integromics partners with FPGMX to develop low-cost methods for clinical genomics
Integromics has entered into a partnership with the Galician Foundation of Genomic Medicine for the development of inexpensive solutions for clinical genomics. 29 Feb 2012

Endomagnetics wins ACES award for most successful university spinout
Endomagnetics is developing advanced magnetic sensing technology for use in breast cancer staging, based on technology developed between University College London and at the University of Houston. 23 Feb 2012

Feature: Medtech industry will start to change the delivery of its communications in 2012
Tristan Jervis, Director at De Facto Communications, explains how the medtech industry, not unlike the pharma industry of 10 years ago, is in the midst of a gradual reform of its modus operandi to accommodate a changing economic model and cultural shift bringing innovation closer to the patient. 22 Feb 2012

EOS Imagine raises over €38m on NYSE
NBGI Ventures has announced that its portfolio company EOS Imagine, has raised over €38 million in a successful public offering of shares on the NYSE Euronext. 20 Feb 2012

UCL spinout takes nano-enabled pain therapy to international markets
Support by the UK NanoKTN has helped UCL School of Pharmacy spin-out Nanomerics to take its patented nano-enabled therapeutic technology to international markets. 20 Feb 2012

NHS interest in financing techniques to purchase medical equipment soars
New research from Siemens Financial Services (SFS) has revealed steeply rising interest in leasing in the NHS. The research tracked the number and the value of leasing tenders issued by the NHS. 20 Feb 2012

Sanofi: 2011 Results Benefit from Genzyme Acquisition

Syngenta CEO Announces Record Free Cashflow at Full-Year Results

Gerresheimer Achieves High Growth in the 2011 Financial Year

Siemens Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen

Pepscan Therapeutics Achieves Milestones in Research Collaboration With Janssen R&D Ireland

Southern Scientific moves to Henfield
The move follows the purchase of Southern Scientific in September 2011 by LabLogic Systems. 6 Feb 2012

GE healthymagination Fund invests in Check-Cap's ingestible imaging capsule
GE Financial Services has announced that it has invested in Israeli company Check-Cap Ltd, a developer of an ingestible X-ray imaging capsule that may help detect intestinal polyps and colorectal cancer. 6 Feb 2012

AstraZeneca announces 2,200 R&D job cuts worldwide
AstraZeneca has announced a set of new restructuring initiatives along with its full-year 2011 results today. The programme is expected to lead to 7,300 job losses in total, with 2,200 of those R&D and save $1.6bn annually. 2 Feb 2012

Liverpool universities and hospitals to build 2 million sq ft BioInnovation Centre
The Liverpool BioInnovation Centre is a 2 million square foot project that aims to create up to 5000 high tech jobs and make Liverpool a world class centre of innovation in the life sciences. 2 Feb 2012

Endomagnetics wins CE Approval for Sienna+ Tracer for breast cancer care
The injectable tracer is used in combination with the ultra-sensitive SentiMag instrument in sentinel lymph node biopsy (SLNB), currently the standard of care in tracking the spread of breast cancer. 19 Jan 2012

BerGenBio completes $9m financing for anti-tumour compound development
The financing will be used primarily to take lead compound BGB324 into clinical trials and to develop a companion diagnostic. 19 Jan 2012

MindFrame awarded third patent for Capture LP thrombectomy technology
The company's technology is used to treat ischemic stroke therapy, in which rapid flow restoration and clot retrieval is essential to prevent irreversible deterioration of brain function. 19 Jan 2012

EDMA and Eucomed join forces to create European industry federation
The move aims to enhance the recognition of their joint membership at European level and make them uniquely positioned to address common issues of interest. 17 Jan 2012

St Jude Medical to expand Plymouth, USA campus for Cardiovascular Division
The building will consolidate the company’s current Cardiovascular Division leased locations in Minnetonka and Maple Grove with existing operations at the site. 17 Jan 2012

Midatech secures £6.3m financing for nanomedicine product development
The financing will be used to support clinical development of chemotherapeutic gold nanoparticles designed to target ovarian, lung and breast carcinoma. 17 Jan 2012

Plasticell wins £750k TSB funding for £1.5m stem cell manufacturing project
Plasticell has announced that the Technology Strategy Board has invested in the Company’s CombiCult, the high throughput technology for stem cell research and development. 13 Jan 2012

Sygnature Discovery's new bioscience group fully operational
Sygnature Discovery has announced that its new Bioscience group is already involved in a number of drug discovery activities for clients, including integrated discovery projects and in vitro biology-only projects. 5 Jan 2012

One Nucleus signs agreement with SEHTA for members' access to preferred suppliers
One Nucleus has signed an agreement with SEHTA (South East Health Technologies Alliance) that gives SEHTA members access to One Nucleus Preferred Suppliers through the One Nucleus Purchasing Consortium Scheme. 5 Jan 2012

SEHTA adopts new business model to ensure support for medtech sector
The South East Health Technologies Alliance is to adopt a new business model to enable it to continue to assist its existing members, new members and other organisations. 5 Jan 2012

Artificial skin-making technology for sale following collapse of developer
The Ideas Studio, which has gone into liquidation, developed an automated manufacturing process for Smart Matrix, an artificial skin product owned by the Restoration of Appearance and Function Trust. 18 Dec 2011

Alliance Medical unveils new strategy
The company has developed a new strategic vision focusing on its belief in the importance of “intelligent imaging”. 18 Dec 2011

EIB, EIF and EC launch facility to help technology-based SMEs get loans for RDI
The new risk-sharing instrument for SMEs will be managed by the EIF. In addition, the EIB and the European Commission are to provide extra resources for research infrastructures. Read more to find out what all the acronyms stand for ... 12 Dec 2012

UK Future Technologies Fund backs SEP IV to support high technology businesses
The UK Future Technologies Fund has committed to SEP IV, the latest fund managed by Scottish Equity Partners continuing the support of the European Investment Fund. 12 Dec 2012

Systagenix Wound Management adds two directors to board
Systagenix Wound Management has announced the appointments of Oern Stuge, CEO of ORSCO Life Sciences AG,. and Jack Wilkens, EO of RevDia, as members of the company’s Board of Directors. 3 Dec 2011

Systagenix Wound Management adds two directors to board
Systagenix Wound Management has announced the appointments of Oern Stuge, CEO of ORSCO Life Sciences AG,. and Jack Wilkens, EO of RevDia, as members of the company’s Board of Directors. 3 Dec 2011

US and Asia show strong demand for German medical technologies
Demand for German medical technologies will grow by 6% percent in 2011, according to industry experts, with above average demand from the USA and Asia. 28 Nov 2011

Michelson Diagnostics shareholders invest £1.9m to expand sales of skin cancer scanner
Michelson Diagnostics has announced an investment of £1.912 million by shareholders Octopus Investments, Catapult Venture Managers and individual investors from London Business Angels. 28 Nov 2011

Leica Microsystems acquires Labindia’s Microscopy and Histopathology Divisions
Labindia Instruments Pvt. Ltd. is a leading solutions and service provider in India that has successfully distributed Leica’s products in India for over 20 years. 28 Nov 2011

Sphere Medical floated on AIM
Sphere Medical Holding plc  has announced trading of 18,943,843 additional Ordinary Shares on 18 November on AIM, following First Admission of 17,861,801 Ordinary Shares on 17 November 2011. 23 Nov 2011.

NanoKTN offers advice for applying for £27m Technology Strategy Board funds 
The UK Nanotechnology Knowledge Transfer Network (NanoKTN) is encouraging its members to apply for a share of £27 million made available by the Technology Strategy Board for grants for innovative research and development projects. 22 November 2011

Endomagnetics raises additional funding for novel cancer diagnostics probe
Cambridge-based Endomagnetics has raised funding totalling £1.8 million. The Company has also announced a move to Cambridge and two new appointments as it expands its operations. 23 November 2011

BioCity Nottingham attracts ex AstraZeneca and Pfizer entrepreneurs
Six new companies started by former AstraZeneca Charnwood employees will create 15 jobs within BioCity Nottingham by the end of November,  23 November 2011

MEDICA and COMPAMED driving jobs in the med tech sector
At this years events 4,571 exhibitors presented the entire cross-section of new products, services and processes for increasing efficiency and quality for in and out-patient care to 134,500 visitors. 23 Nov 2011

Smart Solutions winners chosen by North West NHS Innovation Service
Medical experts in Liverpool, Tameside and Warrington are to play a key role in testing three new medical devices chosen as winners of the Smart Solutions for Healthcare competition. 20 Nov 2011

Domainex awarded TSB funding to develop kinase-inhibiting anti cancer drug
Domainex has been awarded a £250,000 grant by the TSB to support the development of a new drug for the treatment of several common cancers. 20 Nov 2011

Record number of exhibitors at Medica 2011
From 16-19 November 2011, the attention of health and medical professionals from around the world will once again focus on Düsseldorf, as the world's largest medical trade fair, MEDICA 2011, World Forum for Medicine, and COMPAMED 2011 get underway. 15 Nov 2011

Rhône-Alpes region's health sector strongly represented at Medica 2011
The Medical Technology Cluster in Saint-Etienne and the I-Care Cluster in Lyons will attend, together with a number of their members. 15 Nov 2011

UK med tech companies lead export push
Companies from across the UK are putting their medical technology products on the international trade map this week when they exhibit at MEDICA. 15 Nov 2011

Cobra Biologics acquires Unitech Pharma Group
The facility in Matfors will bring over 20 years of bio-production experience to Cobra, with their offering complimenting Cobra’s existing expertise and capacity.

Sygnature Discovery and Saretius in strategic alliance for drug discovery
The companies will collaborate to provide a fully-integrated drug discovery service to accelerate clients’ drug discovery programmes into development. 11 Nov 2011

Medical technology innovations from 75 UK companies on display at Medica 2011
The Association of British Healthcare Industries is once again organising the UK Pavilion at MEDICA (Hall 16 Stand G10-3), housing 75 of the UK’s most innovative med-tech companies.

Microsulis microwave ablation sytem approved to show ETL safety mark
This accreditation mark will now appear on Microsulis Medical’s Sulis VpMTA Generator, which powers the Acculis range of microwave tissue ablation devices. 7 Nov 2011

Almac invests £1m in mass spectrometry facilities for analytics services
Almac's new £1m facility at its northern Ireland headquarters houses state-of-the-art mass spectrometers and underlines Almac’s commitment to providing the best analytical facilities for its customers. 23 Oct 2011

QuantumDX licenses nanostructures for DNA sequencing in hand-held devices
Newcastle-based QuantuMDx Group Limited has signed an exclusive license agreement with US nanotechnology developer Nanosys Inc for several patents and patent applications related to the use of nanostructures for biosensors. 23 October 2011

GE announces $100m innovation challenge and $1bn R&D investment in cancer care
GE has launched a new healthymagination initiative to accelerate cancer innovation and improve care and announced a US$100 million global open innovation challenge for breast cancer diagnostics. 2 Oct 2011

Loxbridge in $7m joint venture with Dr Kary Mullis to develop novel therapeutics
The new company, Altermune Technologies LLC, will focus on the development of novel therapeutics to combat resistant pathogens such as MRSA, C. difficile, pseudomonas, and pandemic flu. 2 Oct 2011

Biogen Idec acquires Dompé joint ventures
Biogen Idec will acquire 100% of Dompé shares in its joint ventures in both Italy and Switzerland. 20 Sept 2011

NuGEN and Advanced Liquid Logic to co-develop digital microfluidic cartridge technology
Advanced Liquid Logic will provide instrumentation, software and digital microfluidic cartridge technology to NuGEN for commercialization. 20 Sept 2011

North West Fund for Biomedical makes first investment in Liverpool start-up
The North West Fund has made its first investment in telemedicine, in Merseyside start-up company Med ePad. 8 September 2011

Sequenom and Lifecodexx partner to develop non-invasive test for trisomy 21
The companies have agreed to collaborate in the development and launch of a trisomy 21 laboratory developed test and other aneuploidies testing in German speaking countries in Europe. 31 August 2011

Hitachi Aloka Medical marks European debut at World Congress of Ultrasound in Medicine and Biology
Hitachi Medical Corporation and Aloka Corporation have combined their strengths in ultrasound to form Hitachi Aloka Medical Ltd a subsidiary of Hitachi Medical Corporation. 24 August 2011

New centre for radiopharmaceutical development at University Hospital Munich
PET Net GmbH has reached an agreement with the University Hospital of Munich to install a new center for radiopharmaceutical development and production. 13 August 2011

apceth granted German licence to produce somatic cell therapeutics
Munich-based apceth has become on of the first companies in Germany to be granted a manufacturer's licence for the production of somatic cell therapeutics pursuant to Section 13, German Medicines Act. 13 August 2011

Evangelisches Krankenhaus Bielefeld signs ten-year radiology agreement with Siemens
German hospital operator Evangelisches Krankenhaus Bielefeld (EvKB) has signed a ten-year partnership agreement with Siemens Healthcare to provide and maintain a new radiology suite. 11 August 2011

Mirador Biomedical receives CE mark for Compass pressure measurement platform
Seattle-based Mirador Biomedical, Inc has received CE Mark approval and an ISO 13485 Quality Management System Certification for its Compass platform . 10 August 2011

Aberdeen University spinout to commercialise antibodies
Vertebrate Antibodies (VAb) Limited is a new biotech company spun out of the University of Aberdeen to provide new tools to help researchers trying to understand the biology and process of diseases that affect humans and animals. 10 August 2011

Opportunities for medical device manufacturers in motorsport industry
There are many shared values in the production of components for the medical and motorsport industries, from the highest degree of engineering integrity to the paramount value of reliability. 5 August 2011

Granton Medical offers clean packing solution for surgery-ready products
Sheffield-based Granton Medical is offering a new service for the healthcare and medical marketplace, providing a customisable medical device packing solution. 5 August 2011

Michelson Diagnostics targets US market for skin cancer imaging products
Michelson Diagnostics has announced plans to expand availability of its revolutionary products for skin cancer imaging in the United States with the formation of a US subsidiary. 5 August 2011

Lophius Biosciences closes €1.4m additional financing
Lophius Biosciences, a developer of novel, innovative T-cell-based diagnostic test systems, has announced the closing of an additional financing round totaling €1.4 million. 5 August 2011

Maxim acquires MEMS developer SensorDynamics
Maxim Integrated Products has acquired Austrian company SensorDynamics, a privately held semiconductor company that develops proprietary sensor and microelectromechanical (MEMS) solutions. 5 August 2011

Toumaz in joint venture with CCE to market Sensium Digital Plaster
Toumaz has established a new joint venture with California Capital Equity to expand the commercialisation and distribution of the Sensium Digital Plaster. 30 July 2011

Source BioScience receives NHS approval for automated cervical cancer screening technology
NHS Cancer screening Programmes has approved the use of Source BioScience BD FocalPoint 'No Further Review' technology for cervical cancer screening in the UK. 27 July 2011

Pneumacare awarded CE mark for  revolutionary respiratory measurement systems
Pneumacare's novel PneumaScan devices that use 3D imaging technology for measuring and assessing respiration. 27 July 2011

Paris hospitals’ technology transfer arm generates €17m revenue
Assistance Publique-Hôpitaux de Paris generated 17 million in revenues thanks to its technology transfer arm, OTTLIV, in 2010. 27 July 2011

Siemens’ Biograph mMR system receives FDA clearance
Biograph mMR is the world’s only fully integrated whole-body molecular MR with simultaneous magnetic resonance and positron emission tomography data acquisition.  4 July 2011

Xceleron announces new board and executive appointments
York-based Xceleron has announced that Dr David Roblin has been appointed to its Board of Directors in a non-Executive capacity and Dr Stuart Best has joined the company as Senior Director Operations. 14 June 2011

Plessey Semiconductors wins award for novel electric field sensor technology
The EPIC sensor is a completely new area of sensor technology that measures changes in an electric field in a similar way to a magnetometer detecting changes in a magnetic field. 9 June 2011

SPARK Impact expands investment team for North West Fund for Biomedical
Early stage venture capital company SPARK Impact, which manages the £25m North West Fund for Biomedical for parent organisation The North West Fund, has appointed two new staff to its investment team in Liverpool. 9 June 2011

Sheffield to host event promoting high-value medtech manufacturing
Organised by Medilink Yorkshire & Humber, the High Value Manufacturing in Healthcare event to be held on 29 June, will engage with the UK healthcare technologies community to look at the issues relating to high-value added manufacturing. 9 June 2011

Avacta secures second Optim sale in US
Avacta's marketing partner in the US has secured the second Optim sale, to one of the ten largest pharmaceutical companies in the US. 2 June 2011

Capio enhances scientific and industrial competence with new board members
Swedish company, Capio, has appointed a new board of directors and management team to enable further steps in the company’s development.  2 June 2011

French health insurer awards Healthways contract to manage diabetes nationwide
France’s Caisse Nationale d'Assurance Maladie des Travailleurs Salariés (CNAMTS) has awarded US company Healthways in partnership with French consulting firm Altran a contract to expand services for CNAMTS’ Sophia program. 20 April 2011

Omron Healthcare wins iF design awards for blood pressure monitors
Omron Healthcare Co., has won both the iF Product Design Award and Universal Design Award for its blood pressure monitors M6 and M6 Comfort. 19 April 2011

Sheffield Precision Medical expands production
Orthopaedic device manufacturer Sheffield Precision Medical Ltd (SPML) has expanded production following record interest in its services. 19 April 2011

IBA takes 25% stake in German radiopharmaceuticals supplier PET Net
Belgian company Ion Beam Applications (IBA) S.A. has taken a minority stake in PET Net GmbH and PET Net Solutions AG, providers of PET radiopharmaceuticals to nuclear medicine facilities in Germany. 19 April 2011

GE Healthcare and Steris Corporation extend collaboration
GE Healthcare has renewed its collaboration with Steris Corporation to continue offering interventional suites optimized with products from both companies.

Novartis completes merger with Alcon
Alcon will be a new division in Novartis and the second biggest in the company after Pharmaceuticals. The division will be headed by Kevin Buehler, former chief executive of Alcon.

Selvita to provide computational chemistry services for US Institutes for Pharmaceutical Discovery
Krakow-based Selvita has signed an agreement with US drug discovery company the Institutes for Pharmaceutical Discovery (IPD) to provide computational chemistry services. 11 April 2011

British Lung Foundation and Philips Respironics to raise awareness of obstructive sleep apnoea
UK charity, The British Lung Foundation and Philips Respironics, have partnered to create a three year programme that aims to raise public awareness and improve diagnosis of obstructive sleep apnoea (OSA). 11 April 2011

Avacta Analytical signs distribution agreement with DKSH Japan
Avacta Group plc has signed an exclusive agreement for the distribution of Optim, its low volume protein analysis system, with DKSH Japan. 11 April 2011

Digirad launches Ergo solid state nuclear medicine camera
Digirad has launched the Ergo, a new range of solid-state, nuclear medicine cameras. In the UK it is available from Southern Scientific. 11 April 2011

Olympus Surgical Technologies Europe takes over Olympus Surgical UK
Hamburg-based Olympus Surgical Technologies Europe has taken over Olympus Surgical UK, the fifth company to join the expanding corporate network. 4 April 2011

Esaote International NV and Pie Medical Imaging acquire 3mensio
Esaote International NV has taken over 3mensio Medical Imaging BV which has merged with Pie Medical Imaging BV (PMI), a company of the Esaote group. 4 April 2011

Siemens integrates Maquet OR table into angiography system
Maquet has announced that Siemens Healthcare will integrate Maquet’s Magnus operating table in its Artis zeego and Artis zee ceiling interventional systems. 19 March 2011

University of Marburg tests nanometer resolution light microscopes for Leica
The University of Marburg is expanding its cooperation with Leica Microsystems to test a new generation of light microscopes with a resolution at the nanometer scale. 19 March 2011

RainDance Technologies and Ambry Genetics collaborate to develop ADME genetic screening panel
RainDance Technologies, Inc. and Ambry Genetics have announced a new collaboration for the development of a drug absorption, distribution, metabolism, and excretion (ADME) genetic screening panel for use on next-generation sequencing (NGS) systems. 19 March 2011

CEA-Leti and partners to develop novel injectable tracer for cancer treatment
CEA-Leti has announced that with four French partners it is developing an injectable tracer that can provide both nuclear imaging in the pre-operative evaluation of tumors and optical imaging during ablation or biopsy. 19 March 2011

Partnership to accelerate human protein kinase drug discovery
UK company IOTA Pharmaceuticals, Danish company KinaseDetect and Swedish company SARomics Biostructures have formed the KINOMED Partnership to accelerate human protein Kinase drug discovery. 7 March 2011

Astra Tech announces strategic alliance with 3Shape for lab-based scanning
Astra Tech, a developer of implant dentistry and CAD/CAM abutments, has announced a global strategic alliance with 3Shape A/S, the Danish-based provider of 3D scanners and CAD/CAM software solutions. 4 March 2011

GE Healthcare completes acquisition of Orbotech Medical Solutions
GE has completed the acquisition of Orbotech Medical Solutions, a manufacturer of cadmium zinc telluride (CZT) detectors used in GE Healthcare’s Alcyone nuclear medicine technology. 22 Feb 2011

Enzybel joins US Science Center Port Business Incubator
Enzybel International, a Belgian company dedicated to the production and commercialization of natural compounds, has established a US office at the University City Science Center’s Port Business Incubator in Philadelphia. 22 Feb 2011

Agilent Technologies and GE Healthcare join WIN consortium
The Worldwide Innovative Networking in Personalized cancer medicine Consortium is a joint initiative from the Institut Gustave Roussy and the University of Texas MD Anderson Cancer Center. 22 Feb 2011

Physio-Control and BeneChill partner to market therapeutic hypothermia system
Physio-Control, a wholly-owned subsidiary of Medtronic and BeneChill, Inc a pioneer in portable therapeutic cooling systems have formed a strategic partnership to launch the RhinoChill IntraNasal Cooling System in Europe. 22 Feb 2011

Creganna-Tactx Medical and BBA in partnership to provide medical device consulting services
The partnership will provide Creganna-Tactx Medical customers with dedicated access to clinical, regulatory and quality expertise and consulting services. 22 Feb 2011

Microsulis sells microwave endometrial ablation technology to Hologic
Microsulis Medical Limited is to discontinue sales of its Microwave Endometrial Ablation system for gynaecology and female urology and has licensed the technology to Hologic Inc. 21 Feb 2011

Partek and Ion Torrent in partnership to distribute genomics software
Bioinformatics developer Partek Incorporated has signed a distribution agreement with Ion Torrent Systems, to make the Partek Genomics Suite available directly through Ion Torrent’s online store. 21 Feb 2011

Sanofi Aventis in US$20bn takeover of Genzyme
Genzyme will expand Sanofi Aventis' presence in biotechnology and will become its global center for excellence in rare diseases.

Care UK expands diagnostic imaging services to UK GP commissioning consortia
Care UK has expanded its capability to provide imaging services to GP consortia through the acquisition of an 80% stake in medical imaging company SMI Ltd. 15 Feb 2011

STI Capital acquires Cardionetics
Cardionetics Limited specialises in the development of advanced algorithms for ECG analysis and this acquisition gives STI a ready-made range of handheld ECG devices. 7 Feb 2011

DBV Technologies closes US$25.5m financing round
The company's products are designed to epicutaneously (via a skin patch) deliver allergens for epicutaneous immunotherapy (EPIT) against food allergies such as peanut and milk. 7 Feb 2011

VAXIMM secures a further CHF7.8m private financing
Swiss biotech firm and Merck KGaA spin-off VAXIMM AG closed a private financing round totalling CHF7.8 million from new and existing investors in January. 7 Feb 2011

DHL wins US and Brazilian approval for European contract manufacturing
DHL Supply Chain’s Contract Manufacturing operation in The Netherlands has passed GMP audits with the US FDA and the Brazilian FDA ANVISA. 7 Feb 2011

Oxford Medical Diagnostics adds Prof Graham Richards to Science Advisory Panel
Professor Richards, head of the Centre for Computational Drug Discovery at Oxford University, brings his considerable expertise in life sciences and developing technology-based start-up companies. 7 Feb 2011

Telemis expands in Italy with acquisition of Micromedica
Belgian medical imaging systems developer Telemis has further consolidated its position in Italy with the acquisition of Micromedica Ltd, one of the country’s leading PACS vendors. 7 Feb 2011

Aureus Pharma changes name to Aureus Sciences
Aureus Pharma has changed it name and launched a new web portal to bring better access to its range of advanced drug discovery tools and knowledge. 7 Feb 2011

Microvisk secures £6 million to launch world’s first diagnostic SmartStrip
SmartStrip is a disposable strip that uses embedded sensors to work out the clotting speed of blood from a finger prick sample and the results are displayed on a handheld reader. 4 Feb

Microfluidics announces PureNano as brand name of MRT technology applications
Microfluidics has rebranded its innovative MRT nanoparticle creation technology as the PureNano platform, featuring the PureNano Continuous Crystallizer. 4  Feb

Caliper and Seegene partner to provide multiplex molecular diagnostics products
Caliper Life Sciences, Inc. and Seegene, Inc. have entered into a strategic partnership to enable Seegene's SeePlex multiplex diagnostic assays to run on Caliper's innovative LabChip Dx platform. 31 Jan 2011

Varian receives US clearance for proton therapy system
Varian Medical Systems has received FDA 510(k) clearance for its proton Therapy System which generates protons for precision radiotherapy of lesions, tumours, and conditions where radiation treatment is indicated. 31 Jan 2011

Caliper and Seegene partner to provide multiplex molecular diagnostics products
Caliper Life Sciences, Inc. and Seegene, Inc. have entered into a strategic partnership to enable Seegene's SeePlex multiplex diagnostic assays to run on Caliper's innovative LabChip Dx platform. 31 Jan 2011

Real-time vital signs data provider Isansys Lifecare makes company debut
The new business will focus on providing continuous, real-time patient data to healthcare professionals using the Isansys Lifecare Platform. 28 Jan

Kromek wins US$4m contract to develop advanced breast cancer diagnosis system
The contract represents one of very few scientific programmes, globally, with the potential to dramatically improve the way in which breast cancer is detected and subsequently treated. 21 Jan 2011

Polyplus-transfection raises €2.5 million in latest funding round
This new round brings in new shareholders in Polyplus-transfection, AIRFI (Alsace Inter Regio Fonds d’Investissement) and Sudinnova, which have invested €1 million and €0.5 million, respectively. 21 Jan 2011

BD and Bruker collaborate to transform bacterial and fungal diagnostics
The companies have formed a co-development and co-marketing collaboration that will promote an emerging, integrated approach to bacterial and fungal identification and antimicrobial susceptibility testing.  21 Jan 2011

Siemens Healthcare creates UK clinical products division for X-ray and ultrasound
The new division brings together mammography, ultrasound, general X-ray, fluoroscopy, mobile X-ray and urology imaging under one team to focus on growing market share. 21 Jan 2011

Hologic acquires uterine fibroid system developer Interlace Medical
Hologic, Inc. a developer of  diagnostics, medical imaging systems and surgical products for women's health has acquired Interlace Medical, Inc. a developer and manufacturer of the MyoSure hysteroscopic tissue removal system. 13 Jan 2011

Gynesonics receives EU clearance for uterine fibroid treatment
The VizAblate System is a transcervical device that combines ultrasound image guidance with radiofrequency ablation to treat fibroids in an outpatient setting. 13 Jan 2011

Boston Scientific acquires deep brain stimulation company Intelect Medical
Boston Scientific is paying $60m for the company which is developing the GUIDE DBS programming system, a system to enable clinicians to visualize stimulation fields in the brain and provide more precise targeting of therapy. 13 Jan 2011

iCAD completes acquisition of Xoft
Cancer diagnostic imaging systems developer iCAD, Inc. has completed the previously announced acquisition of Xoft, Inc., developer of the Axxent eBx electronic brachytherapy system. 7 Jan 2011

Thermo Fisher Scientific completes acquisition of Lomb Scientific
Lomb Scientific is a provider of laboratory chemicals, consumables and instruments in Australia and New Zealand. 7 Jan 2011

GE and Russian Technologies form joint venture to manufacture medical devices
GE and state corporation Russian Technologies (Rostekhnologii) are to form a joint venture to manufacture, assemble, sell and service medical diagnostic equipment in Russia. 7 Jan 2011

Public-private partnerships in healthcare worldwide worth US$70 trillion up to 2020
The rapidly increasing costs of healthcare worldwide will spur governments to use public-private partnerships to improve efficiencies, according to PwC's Health Research Institute. 6 Jan 2011

Accovion expands presence in Europe
Accovion has established two additional subsidiaries in the Czech Republic and in Russia. 21 Dec 2010

Philips partnerships accelerate development of magnetic particle imaging
Royal Philips Electronics has initiated a German public-private partnership to develop whole-body magnetic particle imaging (MPI) systems and preclinical hybrid systems that combine MPI with magnetic resonance imaging (MRI). 21 Dec 2010

MDxHealth renews methylation biomarker agreement with Veridex
MDxHealth SA has renewed its agreement with Veridex for the use of certain of its proprietary DNA methylation products in blood testing for colorectal cancer and prostate cancer screening. 16 Dec 2010

Bio Nano Consulting expands into China
Bio Nano Consulting (BNC), specialists in bio and nanotechnology partnerships between the academic and industrial sectors, has signed up two prominent academics based at China’s Tsinghua University to its pool of consultants. 16 Dec 2010

Science Warehouse to supply transaction management systems to Eurofins Scientific
Science Warehouse will provide its purchasing and transaction management solutions to the eight Eurofins Scientific sites across the UK. 16 Dec 2010

iSOFT moves into life sciences market
iSOFT Group Limited has moved into the life sciences market with software that extracts and de-identifies clinical data from electronic medical records for clinical research and other secondary uses. 16 Dec 2010

Plasticell and Sigma-Aldrich collaborate to develop novel stem cell differentiation protocols
Plasticell will own resulting protocols for high efficiency, directed differentiation of stem cells, with Sigma-Aldrich marketing the reporter stem cell lines. 10 Dec 2010

St Jude's five-column neurostimulation lead gains EU and Australian approval
St Jude Medical has received European CE and Australian approval for  its Penta surgical lead for neurostimulation therapy. 10 Dec 2010

Covidien receives US clearance for iDrive powered surgical stapling system
Covidien has received US FDA clearance for its iDrive powered surgical stapling system. This reusable stapling platform is battery-powered, enabling one-handed push-button operation of all primary controls. 10 Dec 2010

Merck gains novel insulin technology with acquisition of SmartCells
Merck is to acquire SmartCells, a private company developing a glucose responsive insulin formulation for the treatment of diabetes mellitus in a deal worth over US$500m. 10 Dec 2010

Universal flu vaccine to be tested in Indonesia
Australia and Indonesia are collaborating to produce and trial a universal flu vaccine. The new vaccine, GammaFlu, provides cross-protection against current influenza viruses as well as any other unknown strains that may arise in the future. 10 Dec

Genzyme completes sale of genetic testing business to LabCorp
Genzyme has completed the sale of Genzyme Genetics to Laboratory Corporation of America Holdings for $925 million in cash. 10 Dec

Boston Scientific to sell neurovascular business to Stryker for US$1.5bn
The business employs approximately 1,150 people and reported 2009 revenues of US$348 million.

Philips announces new COPD alliance and medical innovations at Medica 2010
Philips new alliance is expected to result in better treatment access for patients. It is also displaying innovations for operating rooms, healing lighting, patient monitoring and cardiac ultrasound. 17 Nov 2010

GE Healthcare integrates facility management software with AeroScout's Wi-Fi RFID system
The combined solution adds real-time asset location information to GE's Maintenance and Facility Management software and helps streamline key business processes. 17 Nov 2010

Sustainability is key theme for Siemens at Medica 2010
At this year's trade fair in Düsseldorf the company will be presenting solutions that enable hospitals to achieve both their economic and their environmental goals while at the same time increasing the quality of patient care. 17 Nov 2010

German medtech sector sales grow 5.5% in 2010
A survey by BVMed has found that the German medical technology sector has shown good performance in 2010, with an increase in sales of 5.5% and are strong in innovation and growth, creating new jobs. 12 Nov 2010

Bio Nano Consulting completes transition to self-funding organisation
Bio Nano Consulting (BNC), specialists in bio and nanotechnology  partnerships between the academic and industrial sectors, has completed its publicly funded phase of corporate development. 12 Nov 2010

Linde Healthcare launches new funding for innovative gas-based therapies
German company Linde Healthcare has launched the Linde Healthcare REALfund to support and stimulate novel and innovative ideas, research and projects relating to the use of gases healthcare. 12 Nov 2010

Birmingham University and Abingdon Health launch diagnostics joint venture
The University of Birmingham and medical diagnostics specialists, Abingdon Health Ltd have launched Bioscience Ventures Limited to develop and market new diagnostics products for the healthcare and other industries. 12 Nov 2010

Plasticell to collaborate with UCB to develop small-molecule drugs
UCB will supply Plasticell with drug compound libraries with known biological targets. Plasticell will screen these using its CombiCult technology to discover new cell signalling pathways. 12 Nov 2010

Siemens Healthcare wins UK Excellence Award
The British Quality Foundation (BQF) has awarded Siemens Healthcare the UK Excellence Award 2010 in recognition of outstanding  management practice and business success. 12 Nov 2010

Boston Scientific to sell neurovascular business to Stryker for US$1.5bn
The business employs approximately 1,150 people and reported 2009 revenues of US$348 million.

Venn Life Sciences expands into France with acquisition of DCI
DCI offers clinical trial management services for Phase I-IV and contract placement solutions for clinical research projects. DCI brings extensive knowledge of the French clinical trial industry. 9 Nov 2010

Dyadem opens office in Germany
Enterprise risk management system supplier Dyadem has opened a second office in Europe, located in Starnberg, Germany, on the outskirts of Munich. 9 Nov 2010

Nordson completes acquisition of Micromedics
Nordson Corporation has completed the acquisition of St Paul, Minnesota-based Micromedics Inc., a producer of dispensing biomaterials for controlling bleeding, healing wounds and other related medical procedures.  3 Nov 2010

IBA to install proton therapy centre in Tennessee
Belgian company IBA has been awarded a contract by ProVision Trust and The Proton Therapy Center, LLC (TPTC) to install a proton therapy facility in Knoxville, Tennessee. The contract is worth US$70-80 million over 10 years. 3 Nov 2010

GE Healthcare to acquire Orbotech's nuclear medicine technology
GE Healthcare is to acquire Orbotech's subsidiary Orbotech Medical Solutions Ltd, a manufacturer of solid state gamma radiation detectors made of cadmium zinc telluride (CZT) for medical imaging. 2 Nov 2010

GE Healthcare takes over molecular diagnostics company Clarient
Clarient is a supplier of oncology testing and diagnostic services and developer of companion diagnostic markers for a range of cancers. 2 Nov 2010

Almac integrates drug development services into new US headquarters
Almac has completed the first phase of relocating employees from three business units to the new 240,000 square feet state-of-the-art integrated drug development facility. 26 Oct 2010

TRaC appoints Chinese partner for European certification and testing
Regulatory compliance company TRaC has announced the appointment of Guangzhou Certitek Testing Service Co Ltd to the TRaC Partner Programme. 26 Oct 2010

Medtronic to distribute Tissuemed's neurosurgical film
Leeds-based Tissuemed has entered into a distribution agreement with Medtronic in which Medtronic will distribute Tissuemed's Obex NeuroFilm Cerebrospinal Fluid Barrier in markets outside the US. 22 Oct 2010

Leads to Development opens new offices in London and Lyon
L2D is a pioneering business created to manage the non-clinical aspects of development projects for biotech and pharmaceutical companies. 22 Oct 2010

Almac invests $4m in biocatalysis business 
Almac is continuing to both advance the biocatalysis business and to broaden application of its biocatalysis expertise with a further US$4m R&D investment. 22 Oct 2010

3M completes acquisition of Arizant
3M has completed its acquisition of Arizant Inc., a manufacturer of patient warming solutions designed to prevent hypothermia in surgical settings. 21 Oct 2010

Nuevolution in collaboration to develop drugs for epigenetic disorders
Copenhagen-based Nuevolution is collaborating with EpiTherapeutics, ExpreS2ion Biotechnologies and the Biotech Research & Innovation Centre (BRIC), University of Copenhagen, to identify and develop novel small molecule drugs against epigenetic factors. 21 Oct 2010

Anaxsys secures £1m funding for respiratory sensor technology
The new investment will allow Anaxsys to accelerate the commercialization of respiR8, its first product, and further the development of a range of innovative respiratory devices. 15 Oct 2010

Untapped resources for UK life science company start-ups
A new report shows that there are vast, untapped opportunities to start up and develop life science companies across the UK. The report calls for public investment to be better targeted at four UK ‘hot spots’. 15 Oct 2010

Kinaxo and Daiichi Sankyo in cancer drug development collaboration
German biotechnology company Kinaxo Biotechnologies GmbH has signed a long-term partnership agreement with Japanese company Daiichi Sankyo Company Limited to develop cancer drugs. 1 Oct 2010

Recipharm acquires Abbott's Spanish biopharmaceutical manufacturing
Swedish company Recipharm AB has acquired Abbott’s manufacturing site near Barcelona, Spain for an undisclosed sum.
The site, which will now be called Recipharm Parets SL. 1 Oct 2010

St Jude gains Japanese approval for spinal cord stimulation system
St Jude Medical, Inc. (NYSE:STJ) has received Japanese approval to market its Eon Mini spinal cord stimulation (SCS) system in the country. 1 Oct 2010

IBA sells first carbon beam therapy system
Belgian company IBA has sold the prototype of its next generation carbon therapy system to French company CYCLHAD and signed an R&D agreement with Saphyn to jointly develop the potential of carbon beam therapy. 23 Sept 2010

Philips acquires second Brazilian clinical information systems company
Philips Healthcare is to acquire a second Brazilian clinical systems supplier, Wheb Sistemas. It follows the March 2010 acquisition of Tecso Informatica, one of Brazil’s leading radiology information systems (RIS) suppiers. 17 Sept 2010

3M acquires Arizant's patient warming business for $810m
3M has agreed to acquire Arizant Inc. for $810 million in cash. Arizant is a manufacturer of patient warming solutions designed to prevent hypothermia in surgical settings. 15 Sept 2010

LabCorp in $925m takeover of Genzyme Genetics
Laboratory Corporation of America Holdings has agreed to acquire Genzyme Genetics, a business unit of Genzyme Corp and a leading provider of complex reproductive and oncology testing services. 15 Sept 2010

Russia assembles first CT scanner
GE Healthcare and its Russian manufacturing partner Meditsinskie technologii Ltd (MTL) have unveiled Russia's first domestically assembled CT scanner. 15 Sept 2010

Canon announces ophthalmic diagnostics plans following takeover of Optopol
Canon Europe has announced first details of its plans for world domination in the ophthalmic diagnostic equipment market. 15 Sept 2010

MorphoSys starts novel drug development program for MRSA infections
MorphoSys AG has started a new proprietary development program against novel infectious disease targets. It is also collaborating with Sheffield-based Absynth Biologics to access novel target molecules related to MRSA. 15 Sept 2010

Elemental Healthcare to distribute GI Dynamics' gastrointestinal liner in UK and Ireland
GI Dynamics has licensed Elemental Healthcare to distribute its EndoBarrier Gastrointestinal Liner,  a non-surgical therapeutic for the treatment of type 2 diabetes and obesity. 9 Sept 2010

iBio and Fraunhofer partner GE to develop biotechnology manufacturing systems
iBio, the Fraunhofer USA Center for Molecular Biotechnology, and GE Healthcare have entered an agreement to jointly develop and globally market manufacturing systems for biopharmaceuticals and vaccines based upon their respective proprietary technologies. 9 Sept 2010

New company combines F1 technology with physiotherapy for rehabilitation
The Gatherer Partnership, a new company that combines technology from Formula One racing with the experience of one of Britain’s most renowned research physiotherapists, aims to advance patient rehabilitation and conditioning techniques. 9 Sept 2010

Vivacta re-aligns management in preparation for £4 million financing round
Kent-based diagnostics technology company Vivacta Limited has announced a change and re-alignment of its executive management team as it enters an important phase of partnering and commercialisation. 26 August 2010

Cegedim Dendrite and Capgemini partner to offer services to life science companies
Capgemini will provide broad-based consulting and implementation services associated with Cegedim Dendrite’s AggregateSpend360 and Nucleus 360 solutions to pharmaceutical, biotech and medical device companies. 18 August 2010

Scancell licences human antibody from Cancer Research Technology
Cancer Research Technology has licensed Nottingham University spinout Scancell Holdings to use a human antibody known as 105AD7. 18 August 2010

Cytori’s PureGraft receives EU approval for fat grafting procedures
Cytori Therapeutics has received the CE Mark for the PureGraft 250/PURE System for autologous fat grafting procedures. It is aimed at the cosmetic and reconstructive surgery market. 18 August 2010

Akonni Biosystems’ ultra-rapid nucleic acid extraction technology gains US patent
The patent protects the company’s use of its pioneering nucleic acid binding matrix when inserted into a pipette tip, tubing or cartridge for nucleic acid purification. 18 August 2010

Medical equipment deals briefing for Q2 2010
Mergers and acquisitions activity decreased. There was a decrease in value over Q1 mainly due to a large acquisition by Novartis in Q1. The number of deals also decreased from 110 in Q1 to 78 deals in Q2 2010. The most active buyers were Essilor International with 14 deals, followed by Covidien plc with eight. more ...

Epson partners with Philips to offer printing systems for ultrasound imaging worldwide
Epson America and Royal Philips Electronics have entered into an agreement to supply Epson ink jet printers with Philips ultrasound medical imaging systems around the world. 17 August 2010

Ion Torrent licences DNA Electronics technology
DNA Electronics Ltd has signed a worldwide licence agreement giving Ion Torrent access to its intellectual property. DNA Electronics has developed scalable semiconductor solutions for real-time nucleic acid detection. 13 August 2010

iSOFT partners i-Path to add digital pathology to laboratory system
iSOFT is adding i-Path’s web-based platform as a module to its existing laboratory product suite. The aim is to deliver the solution under a software-as-a-service model. 13 August 2010

TRaC accredited for IEC/EN60601 medical device testing
TRaC is now able to offer a cost-effective route to product certification. Approval under the standard is a fundamental requirement before a manufacturer can market any electrical device for patient diagnostics, monitoring or care. 13 August 2010

Clontech Laboratories and TET Systems extend gene expression systems license agreement
Under the expanded license agreement, Clontech obtains rights to develop, manufacture and commercialize novel Tet Systems products such as the Tet-On 3G Inducible Expression System. 11 August 2010

Pharmaceutical Development Services and Schiff & Company form alliance
PDS will be providing Regulatory and Quality Services to Schiff & Company clients in Europe while Schiff & Company will be targeting US based companies looking for local assistance in Europe. 11 August 2010

Siemens wins 15-year €132m medical imaging contract in Spain
Siemens will provide the Cartagena and Mar Menor hospitals with more than 100 imaging systems, including computed tomography scanners, mammography systems, and ultrasound systems. 11 August 2010

Philips acquires Israeli PACS supplier CDP Medical
Philips has agreed to acquire the business of CDP Medical Ltd, an Israel-based provider of picture archiving and communication systems (PACS), and a subsidiary of medical device distributor Medtechnica Ltd. 2 August 2010.

Philips acquires Chinese ultrasound transducer producer Shanghai Apex Electronics Technology
The acquisition strengthens Philips’ portfolio of high quality transducers specifically aimed at the value segment in emerging markets. 2 August 2010

Varian and Brainlab Combine TrueBeam STx with the Novalis Radiosurgery Program
Varian Medical Systems and Brainlab are expanding their radiosurgery partnership to incorporate their Novalis technology and other Novalis radiosurgery program elements into the recently launched TrueBeam STx system. 2 August 2010

Cambridge Crystallographic Data Centre and InhibOx partner to offer drug development services
The combined service offers pharmaceutical, biotech and governmental research organizations access to new capabilities to accelerate drug discovery and improve productivity. 2 Aug 2010

Target Health joins forces with LifeOnKey to offer clinical trials platform
Target Health and LifeOnKey are partnering to offering a platform for the bio-pharmaceutical and medical device industries to optimize clinical trials help researchers capture, analyze and assess trial data more efficiently. 26 July 2010

Medical Device Consultants in partnership with Clinical Development & Support Services
US contract research organization (CRO) Medical Device Consultants, Inc. (MDCI) has announced a strategic partnership with Clinical Development & Support Services Ltd (CDSS), a clinical services and CRO based in Cheshire, UK. 26 July 2010

Health Robotics expands CytoCare market into Spain and Portugal
Health Robotics has announced it has granted exclusive rights to Grifols S.A. to distribute its CytoCare chemotherapy system in Spain and Portugal. 26 July 2010

BRAIN takes share in Enzymicals
German biotechnology company BRAIN AG has acquired a minority share in chemical and biocatalyst specialist Enzymicals AG. The move enhances the activities of both companies in the biocatalysis sector. 15 July 2010

Covidien completes acquisition of ev3
Covidien has announced the completion of the acquisition of ev3 Inc. for approximately US$2.6 billion. The transaction accelerates Covidien’s strategy of building a world-class vascular platform addressing high-growth markets. 15 July 2010

P2i expands nano-coating portfolio with acquisition of Surface Innovations
Abingdon based P2i Limited, a world leader in liquid repellent nano-coating technology, has acquired Surface Innovations Ltd, a UK-based technology company with a wide range of functional nano-coating patents. 15 July 2010

St Jude Medical completes takeover of LightLab Imaging
St Jude Medical has completed the acquisition of LightLab Imaging, Inc. for approximately $90 million in cash. LightLab is a pioneer and leader in the development of Optical Coherence Tomography (OCT), a high resolution diagnostic coronary imaging technology. 14 July 2010

Alcon to acquire cataract surgery laser developer LenSx Lasers
Alcon, Inc. has agreed to acquire LenSx Lasers, Inc, a privately held company that developed the first femtosecond laser to receive US FDA clearance for use as a part of cataract surgery. 14 July 2010

Roche Applied Science Industrial Business relaunched as Roche Custom Biotech
The relaunch is to increase brand recognition in the life science, pharmaceutical, and diagnostic industry. 14 July 2010

Proton therapy company formed to establish network of treatment centres
Proton Therapy USA and CareCapital plc have formed a new company, Proton Therapy Global Management, to design, develop and manage a global network of proton therapy centres. 30 June 2010

 Pharmimage adds members and extends research platform
Pharmimage, a French group specialized in the use of imaging to measure the efficacy of new therapies for the pharmaceutical industry, has acquired four new members and plans two major additions to its research resources. 23 June 2010

Centocor Ortho Biotech acquires lung disease portfolio in takeover of Respivert
Centocor Ortho Biotech Inc., a subsidiary of Johnson & Johnson, has acquired RespiVert Ltd., a privately held drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of pulmonary diseases. 23 June 2010

Polyplus-transfection licenses mammalian transient transfection technology to Kempbio 14 June 2010

Biotage extends peptide research collaboration with University of Copenhagen
Biotage has extended a research collaboration with the University of Copenhagen to develop new applications on the Biotage Syro Wave in the field of synthetic peptide and protein chemistry. 12 June 2010

Almac and University College Cork collaborate in solid state chemistry
UCC and Almac have launched an academic/ industrial collaboration in the field of solid state chemistry to advance drug development. 12 June 2010

Giltech and B1 Medical collaborate to develop biodegradable suture anchor
Scottish companies Giltech and B1 Medical have signed an agreement to jointly develop a pioneering suture anchor that biodegrades in a controlled fashion. 8 June 2010

Cellnovo and Home Diagnostics form alliance to advance diabetes monitoring
London-based Cellnovo and US company Home Diagnostics, Inc. have formed a strategic alliance to integrate their diabetes care technologies and develop distribution opportunities for Cellnovo’s insulin patch pumps. 8 June 2010

Intercell acquires monoclonal antibody technology from Cytos Biotechnology
Cytos' technology is based on expression cloning of monoclonal antibodies from human B-cells and enables the identification of anti-infective antibodies to prevent and treat infectious diseases. 8 June 2010

Elekta acquires ultrasound-guided radiation therapy technology from Resonant Medical Inc
Elekta has acquired Canadian company Resonant Medical Inc. (RMI), specialists in image-guided radiation therapy for cancer treatment. 2 June 2010

Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics
The report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of merger and acquisition agreements from 2003 to end 2009. More information and Buy online May 2010

Particle Sciences offers microfluidics reaction technology for nanoparticle production
Particle Sciences and Microfluidics have extended their collaboration with the placement of the newly-announced Microfluidics Reaction Technology (MRT) system for pharmaceutical production at Particle Sciences. 10 May 2010

Global economic downturn will shrink life sciences sector and R&D spend
Curbing costs in response to the global economic downturn, as well as the continuing capital crunch, is likely to have a long-term impact on the life sciences industries, according to a new white paper released by Deloitte Touche Tohmatsu. 10 May 2010

Olympus merges minimally invasive diagnostics expertise into Olympus Surgical Technologies Europe
Olympus Winter & Ibe GmbH, Celon AG and Olympus Medical Products Czech SPOL SRO have joined forces to create a new, single brand. 14 April 2010

Phico Therapeutics raises further £1.8m to develop new class of superbug antibiotics
Cambridge based Phico Therapeutics, has raised £1.8 million from their recent funding round of institutional investors and business angels to develop new treatments for drug-resistant 'superbugs'. 2 April 2010

Evotec in deal with Hypha Discovery to enhance drug discovery platform
The deal gives Evotec's screening clients access to Hypha’s MycoDiverse natural product collection for use as part of its hit-and-lead services to identify medicinal compounds. 2 April 2010

Eden Biodesign and Millipore in partnership to offer pharmaceutical manufacturing and gene expression technology
The partnership that will provide biopharmaceutical companies with access to a combination of Eden’s cGMP manufacturing and Millipore’s Ubiquitous Chromatin Opening Elements expression technology. 1 April 2010

Future-proofing healthcare innovation in Yorkshire
Healthcare industrialists, clinicians and academics identified future challenges and opportunities for the industry and highlighted the need for high-level innovation at a workshop in Leeds earlier this month run by the newly formed Yorkshire Health Innovation Network. 26 March 2010

Evotec signs agreement with Active Biotech for high throughput molecular screening 
Evotec AG has entered into a collaboration with Active Biotech AB to identify small molecule modulators of a priority biological target, selected by Active Biotech, involved in immune disorders and cancer. 26 March 2010

Leica Microsystems acquires Genetix to strengthen life science imaging portfolio
Leica Microsystems has acquired UK company Genetix Ltd, a provider of systems for imaging and image analysis for clinical research. 25 March 2010

FASILIS project invites innovative medical technology businesses to participate
The European FASILIS project is inviting SMEs or start-ups develloping telecare technology to apply for financial vouchers that will give them access to top quality international research and development facilities and their services across Europe. 25 March 2010

Cresset establishes new division to provide computation chemistry tools
Cresset has launched Versaphor, a new desktop applications division aimed at supplying high quality computational tools based on its molecular fields technology to a range of markets, including: medicinal chemists. 25 March 2010

MedilinkWM extends business service to assisted-living market
The service, myM-Link, delivers access to business opportunities and information services to its members, and a host of tangible benefits that are tailored and dedicated to businesses operating in the UKs assisted living market. 16 March 2010

Avo Photonics systems available in Europe
Avo Photonics and German company AMS Technologies have entered into a distribution agreement that entitles AMS Technologies to represent Avo’s capabilities to the European market. 12 March 2010

WuXi PharmaTech's Shanghai analytical testing facilities gain GMP certification
The company has received European GMP compliance certification for its c-GMP drug product manufacturing and analytical testing facilities. 9 Mar 2010

MedilinkUK and MEDEC partner with UTEK to increase licensing and partnering opportunities
Through this partnership, hundreds of new companies can take advantage of UTEK's growing network of registered companies and industry professionals, all looking to identify licensing and partnering opportunities worldwide. 9 Mar 2010

Evotec extends research agreement with Cubist Pharmaceuticals
Under the contract extension, Evotec will provide additional fragment-based drug discovery expertise using its proprietary platform, EVOlution. 5 Mar 2010

Lilly, Merck, and Pfizer co-operate to accelerate cancer research in Asia
The three companies have formed the Asian Cancer Research Group, to accelerate research and ultimately improve treatment for patients affected with the most commonly-diagnosed cancers in Asia. 23 Feb 2010

PositiveID acquires non-invasive glucose detection technology with takeover of Easy Check
PositiveID Corporation has acquired intellectual property rights and assets of Easy Check Medical Diagnostics, LLC, to expand its portfolio of non-invasive glucose-level testing products and diabetes management tools under development. 23 Feb 2010

Celtic Pharma Holdings and PolyTherics announce investment to develop novel biopharmaceuticals
The research programme will be undertaken jointly by PolyTherics and Cantab BioPharmaceuticals Limited, a subsidiary of CP2 based in Cambridge, UK, and the investment will be by Leverton Licence Holdings Limited (LLH), another subsidiary of CP2. 22 Feb 2010

Quanticate appoints head of new pharmacovigilance services team
The new pharmacovigilance service offers clinical trial and post-marketing pharmacovigilance in order to provide comprehensive surveillance throughout the product lifecycle. 16 Feb 2010

Isogenica in partnership with Phylogica
Isogenica Ltd has entered into an agreement with Australian-based biopharmaceutical company Phylogica to use Isogenica’s CIS display technology to optimize the performance of three of Phylogica’s lead compounds targeting CD40 ligand (CD40L). 15 February 2010

Domainex and Pharmidex form drug discovery services alliance
Domainex Ltd and Pharmidex have formed a strategic alliance, combining their expertise and innovative technologies to provide the market with an integrated, high-quality drug discovery services platform. 11 Feb 2010

Fujitsu joins TRaC partner laboratory programme to support CE certification
Fujitsu General EMC Laboratory Limited has joined the TRaC Partner Laboratory Programme that offers enhanced services to manufacturers wishing to certify products for sale in the UK and Europe. 11 Feb 2010

Awards for West Midlands medtech companies
International demand for infection control solutions and cost-effective manufacturing tools has helped five groundbreaking businesses from the UK West Midlands win awards in the Medical and Healthcare Business Awards 2010, organised by MedilinkWM. 9 Feb 2010

Report on Swedish life science cluster
Stockholm-Uppsala Life Science has published a comprehensive report on the research expertise in the Stockholm-Uppsala region of Sweden.
The region currently hosts over 500 life science companies, 300 major research projects and more than 25,000 employees. 9 February 2010

St Jude Medical gains EU approval for high power ICD and CRT-D devices
St Jude Medical,has announced European CE Mark approval and first implants of its Fortify and Fortify ST implantable cardioverter defibrillators and Unify cardiac resynchronization therapy defibrillator. 9 Feb 2010

QIAGEN Unit and Pfizer in agreement to develop diagnostic kit for brain tumours
The companies will develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). 9 Feb 2010

ISCO opens new facility for stem cell products
International Stem Cell Corporation has opened its new production facility in California that will enable development and manufacturing of clinical-grade products using its human parthenogenic stem cell technology. 9 Feb 2010

Sorin releases new Paradym CRT defibrillator
Sorin Group has announced FDA approval and first implant of its next-generation of cardiac resynchronization therapy defibrillator (CRT-D), Paradym CRT Model 8750. 9 Feb 2010

Automation Partnership and Loughborough University in five-year collaboration to develop regenerative medicine. 5 Feb 2010

Report: Medical Equipment Monthly Deals Analysis — January 2010
The report provides detailed information on M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions registered in the medical equipment industry in December 2009. Jan 2010

Syntaxin announces appointments of senior officers
Syntaxin, a biotechnology company developing novel biopharmaceuticals that control cell secretion, has announced the appointment of a Chief Executive Officer, Chief Business Officer and Chief Development Officer. 1 Feb 2010

Peakdale Molecular in chemistry research collaboration with Pfizer Laboratories
UK research services company Peakdale Molecular Limited has entered into an agreement with Pfizer Limited to supply custom synthetic chemistry services. 1 Feb 2010

NASA to develop microfluidics technology for space-based research with Raydiance
Raydiance Corporation, developer of an ultrafast laser, is partnering with NASA Ames Research Center to develop advanced microfluidics devices for space-based biological experiments. 28 Jan 2010

Medtronic to expand cardiovascular products with acquisition of Invatec
Medtronic, Inc. will acquire Invatec, and two affiliated companies: Fogazzi and German company Krauth Cardiovascular. The takeover will cost Medtronic up to US$500m. 28 January 2010

GE Healthcare invests in global health R&D centre in Korea
GE Healthcare, Incheon Free Economic Zone (IFEZ), and gene analysis technology company BRC, have announced a five-year plan to invest in the establishment of the GE Global Ubiquitous Health Research and Development Center. 14 Jan 2010

Business news:  Now | 2009 | 2008 | 2007 | 2006 | 2005

To top

To top